<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e491pfizer_names_new_svp_of_clinical_development_and_medical_affairs_for_onc/</loc>
		<lastmod>2018-07-04T15:40:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heat-biologics-to-acquire-controlling-stake-in-pelican-therapeutics-090317-5759025/</loc>
		<lastmod>2018-07-04T15:40:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/75497uk_court_upholds_daiichi_sankyos_levofloxaci/</loc>
		<lastmod>2018-07-04T15:40:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4afmerck_announces_corporate_restruct/</loc>
		<lastmod>2018-07-04T15:40:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bergenbio-announces-collaborative-agreement-with-merck-090317-5759009/</loc>
		<lastmod>2018-07-04T15:40:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/generic-drugmaker-apotex-to-invest-184m-for-expansion-in-us-090317-5758737/</loc>
		<lastmod>2018-07-04T15:40:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134acponiard_reports_positive_results_from_phase_ii_colorectal_cancer_/</loc>
		<lastmod>2018-07-04T15:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc4a0wyeth_q3_net_revenu/</loc>
		<lastmod>2018-07-04T15:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f489cytodyn_files_new_ind_application_for_hiv/</loc>
		<lastmod>2018-07-04T15:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/beigene-guangzhou-get-form-jv-for-new-biologics-plant-in-china-080317-5757819/</loc>
		<lastmod>2018-07-04T15:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/idmc-recommends-continuation-of-mereos-bgs-649-phase-2b-trial-080317-5757850/</loc>
		<lastmod>2018-07-04T15:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioversys-aptuit-to-jointly-identify-novel-approaches-to-tackle-gram-negative-pathogens-080317-5757867/</loc>
		<lastmod>2018-07-04T15:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474b9infinity_pharmaceuticals_reports_positive_preclinical_data_from_cancer_/</loc>
		<lastmod>2018-07-04T15:40:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64afantigenics_files_maa_for_cancer_va/</loc>
		<lastmod>2018-07-04T15:40:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelions-chlormethine-gel-gets-ec-approval-to-treat-mf-ctcl-080317-5757520/</loc>
		<lastmod>2018-07-04T15:40:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/serenitys-noctiva-approved-by-fda-for-treating-nocturia-in-adults-070317-5756807/</loc>
		<lastmod>2018-07-04T15:40:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-to-purchase-ctp-656-from-concert-for-cystic-fibrosis-treatment-070317-5756671/</loc>
		<lastmod>2018-07-04T15:40:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74a9threshold_pharmaceuticals_reports_preliminary_results_from_phase_i_cancer_/</loc>
		<lastmod>2018-07-04T15:40:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf4b1astellas_pharma_wins_approval_for_new_formulation_of_hyponatremia/</loc>
		<lastmod>2018-07-04T15:40:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5490merix_pharmaceutical_settles_false_advertising_litigation_wit/</loc>
		<lastmod>2018-07-04T15:40:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44bfnymox_to_complete_new_one_year_bph_drug_/</loc>
		<lastmod>2018-07-04T15:40:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/03491advitech_signs_distribution_agreement_with_pl_thomas/</loc>
		<lastmod>2018-07-04T15:40:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-ind-application-of-advaxis-adxs-neo-070317-5756754/</loc>
		<lastmod>2018-07-04T15:40:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tg-therapeutics-leukemia-drug-meets-primary-end-point-in-phase-3-trial-070317-5756544/</loc>
		<lastmod>2018-07-04T15:40:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-asks-scynexis-to-pause-initiation-of-new-clinical-studies-using-scy-078-iv-formulation-060317-5755547/</loc>
		<lastmod>2018-07-04T15:40:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac49emedtronic_files_premarket_approval_application_for_interstim_th/</loc>
		<lastmod>2018-07-04T15:40:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474a1neuroptix_raises_185_million_in_series_b_fina/</loc>
		<lastmod>2018-07-04T15:40:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea4barxi_pharmaceuticals_names_new_chief_scientific_of/</loc>
		<lastmod>2018-07-04T15:40:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48482mylan_wins_tentative_fda_approval_for_blood_pressure/</loc>
		<lastmod>2018-07-04T15:40:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba4b3alpharx_and_gaia_biopharma_sign_feasibility_and_option_agre/</loc>
		<lastmod>2018-07-04T15:40:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chi-meds-colorectal-cancer-drug-fruquintinib-shows-positive-results-in-phase-3-trial-060317-5755530/</loc>
		<lastmod>2018-07-04T15:40:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cma-accuses-actavis-concordia-of-conspiring-on-hydrocortisone-drug-060317-5755706/</loc>
		<lastmod>2018-07-04T15:40:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimmune-sanofi-pasteur-sign-615m-deal-to-develop-mab-rsv-drug-060317-5755469/</loc>
		<lastmod>2018-07-04T15:40:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64b1smartcells_and_jdrf_partner_in_diabetes_res/</loc>
		<lastmod>2018-07-04T15:40:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab4bfmylan_confirms_patent_challenge_relating_to_l/</loc>
		<lastmod>2018-07-04T15:40:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nice-recommends-intercepts-ocaliva-for-primary-biliary-cholangitis-treatment-030317-5754589/</loc>
		<lastmod>2018-07-04T15:40:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b048emedivation_reports_encouraging_data_from_phase_iii_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c4a4enigma_diagnostics_signs_licensing_agreement_with_applied_biosy/</loc>
		<lastmod>2018-07-04T15:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad4bczymogenetics_reports_positive_interim_results_from_phase_ii_renal_cancer_/</loc>
		<lastmod>2018-07-04T15:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ptcs-cystic-fibrosis-drug-ataluren-fails-in-phase-3-trial-030317-5754499/</loc>
		<lastmod>2018-07-04T15:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-trial-of-perjeta-breast-cancer-combination-drug-meets-primary-end-030217-5754304/</loc>
		<lastmod>2018-07-04T15:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-priority-review-to-celgenes-leukemia-drug-enasidenib-020317-5753411/</loc>
		<lastmod>2018-07-04T15:40:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mrc-awards-grant-to-ucl-researchers-to-develop-novel-autoimmune-therapy-020317-5753380/</loc>
		<lastmod>2018-07-04T15:40:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgens-leukemia-treatment-blincyto-shows-significant-effect-in-phase-3-tower-study-020317-5753087/</loc>
		<lastmod>2018-07-04T15:40:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/404b6merck__co_q3_net_income_/</loc>
		<lastmod>2018-07-04T15:40:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e49bmedivir_files_marketing_authorization_application_for_lip/</loc>
		<lastmod>2018-07-04T15:40:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c481boehringer_ingelheim_presents_positive_results_from_phase_i_tumor_/</loc>
		<lastmod>2018-07-04T15:40:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/esko-announces-strategy-to-help-customers-with-increasing-regulations-on-nutritional-labeling-5759329/</loc>
		<lastmod>2018-07-04T15:40:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d849cponiard_reports_positive_data_from_phase_ii_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:40:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be487exelixis_presents_positive_interim_data_from_phase_i_study_of_tumor/</loc>
		<lastmod>2018-07-04T15:40:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas-affinivax-to-develop-vaccine-for-pneumococcal-disease-010317-5752195/</loc>
		<lastmod>2018-07-04T15:40:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kites-cancer-drug-meets-primary-endpoint-in-car-t-trial-010317-5752166/</loc>
		<lastmod>2018-07-04T15:40:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734a2kylin_therapeutics_expands_cancer_res/</loc>
		<lastmod>2018-07-04T15:40:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f4b2medtronic_launches_new_aortic_aneurysms_treatment_d/</loc>
		<lastmod>2018-07-04T15:40:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a4abtomotherapy_and_novation_sign_supply_agre/</loc>
		<lastmod>2018-07-04T15:40:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24b5mdrna_acquires_rights_to_nucleic_acid_technology_from_rib/</loc>
		<lastmod>2018-07-04T15:40:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/794b6tibotec_announces_fda_approval_for_expanded_indication_of_hiv/</loc>
		<lastmod>2018-07-04T15:40:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/who-wants-urgent-rd-to-tackle-drug-resistant-tb-010317-5752181/</loc>
		<lastmod>2018-07-04T15:40:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-merck-and-pfizers-avelumab-for-metastatic-urothelial-carcinoma-010317-5751804/</loc>
		<lastmod>2018-07-04T15:40:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharma-two-b-raises-30m-in-third-round-of-financing-180217-5750924/</loc>
		<lastmod>2018-07-04T15:40:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b54b9spectranetics_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:40:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/864a8merit_medical_wins_fda_clearance_for_prelude_short_sheath_intro/</loc>
		<lastmod>2018-07-04T15:40:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c484endologix_wins_fda_approval_for_intuitrak_delivery_s/</loc>
		<lastmod>2018-07-04T15:40:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104b0dusa_reports_results_from_phase_iib_acne_/</loc>
		<lastmod>2018-07-04T15:40:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/924b9oculus_introduces_microcyn_wound_care_for_us_podiatry_m/</loc>
		<lastmod>2018-07-04T15:40:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sellas-to-develop-cancer-immunotherapy-agent-using-advaxis-technology-280217-5750902/</loc>
		<lastmod>2018-07-04T15:40:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/la-jollas-crh-drug-meets-primary-endpoint-in-phase-3-trial-280217-5750854/</loc>
		<lastmod>2018-07-04T15:40:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-lonza-to-build-eur270m-biologics-production-facility-in-switzerland-280217-5750548/</loc>
		<lastmod>2018-07-04T15:40:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c4afneurogesx_files_nda_for_dermal_capsaicin_/</loc>
		<lastmod>2018-07-04T15:40:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f849aoxigene_names_ne/</loc>
		<lastmod>2018-07-04T15:40:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b4acstemcor_signs_development_agreement_with_ho/</loc>
		<lastmod>2018-07-04T15:40:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a24afbarr_confirms_patent_challenge_of_opana_er_ta/</loc>
		<lastmod>2018-07-04T15:40:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154a1aires_pharmaceuticals_signs_technology_license_agreement_wit/</loc>
		<lastmod>2018-07-04T15:40:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-recommends-approval-of-novartis-tafinlar-in-combination-with-mekinist-270217-5749697/</loc>
		<lastmod>2018-07-04T15:40:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxford-biomedicas-trovax-phase-iii-trial-yields-encouraging-results-270217-5749677/</loc>
		<lastmod>2018-07-04T15:40:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-recommends-astrazenecas-hyperkalaemia-drug-for-ema-approval-270217-5749617/</loc>
		<lastmod>2018-07-04T15:40:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/184b2immunogen_licenses_tumor_technology_to_bayer_healt/</loc>
		<lastmod>2018-07-04T15:40:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2248bnxstage_signs_supply_agreement_with_renal_adva/</loc>
		<lastmod>2018-07-04T15:40:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb48bviral_genetics_reports_initial_findings_from_lyme_disease_/</loc>
		<lastmod>2018-07-04T15:40:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/484b8derma_sciences_to_introduce_xtrasorb_super_absorbent_dre/</loc>
		<lastmod>2018-07-04T15:40:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584bdmatrixx_initiatives_ceo_to_r/</loc>
		<lastmod>2018-07-04T15:40:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/87489oncure_medical_relocates_headquarters_to_d/</loc>
		<lastmod>2018-07-04T15:40:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4abmetabolon_and_university_of_michigan_sign_development_agre/</loc>
		<lastmod>2018-07-04T15:40:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/434a9vitae_pharmaceuticals_reacquires_rights_to_renin_inhibitor_pr/</loc>
		<lastmod>2018-07-04T15:40:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/494a6laureate_signs_manufacturing_agreement_with_t/</loc>
		<lastmod>2018-07-04T15:40:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b54b2emisphere_announces_initiation_of_second_phase_iii_osteoarthritis_/</loc>
		<lastmod>2018-07-04T15:40:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7849disolagen_completes_injections_of_isolagen_therapy_in_acne_scar_/</loc>
		<lastmod>2018-07-04T15:40:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f48dglycotex_initiates_enrollment_in_phase_iib_study_of_topical_wound_healin/</loc>
		<lastmod>2018-07-04T15:40:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4b8sucampo_europe_reports_positive_data_from_constipation_t/</loc>
		<lastmod>2018-07-04T15:40:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/39498uluru_initiates_first_clinical_study_using_altrazeal_s/</loc>
		<lastmod>2018-07-04T15:40:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d49bglaxosmithkline_to_acquire_lacledes_dry_mouth_brand_bi/</loc>
		<lastmod>2018-07-04T15:40:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-trial-of-inactivated-varicella-zoster-virus-vaccine-meets-primary-end-point-270217-5749349/</loc>
		<lastmod>2018-07-04T15:40:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cyclasels-leukemia-drug-sapacitabine-fails-in-crucial-phase-3-trial-240217-5748624/</loc>
		<lastmod>2018-07-04T15:40:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prometics-pulmonary-fibrosis-drug-yields-positive-results-in-phase-2-trial-240217-5748673/</loc>
		<lastmod>2018-07-04T15:40:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/incyte-abramson-cancer-center-partner-on-oncology-research-240217-5748649/</loc>
		<lastmod>2018-07-04T15:40:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-innovivas-relvar-ellipta-shows-positive-effect-in-non-inferiority-lung-function-study-240217-5748249/</loc>
		<lastmod>2018-07-04T15:40:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immusants-phase-1b-trial-of-celiac-disease-vaccine-meets-objective-230217-5747452/</loc>
		<lastmod>2018-07-04T15:40:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/69483pervasis_therapeutics_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:40:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec4bdcrucell_to_relocate_korean_production_fac/</loc>
		<lastmod>2018-07-04T15:40:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544b9tracon_pharmaceuticals_names_new_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:40:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb4b6active_implants_signs_distribution_agreement_wit/</loc>
		<lastmod>2018-07-04T15:40:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f9483ironwood_reports_positive_results_from_phase_iib_constipation_/</loc>
		<lastmod>2018-07-04T15:40:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pmv-pharma-raises-74m-for-small-molecule-cancer-drugs-230217-5747434/</loc>
		<lastmod>2018-07-04T15:40:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/idmc-recommends-to-halt-argos-cancer-vaccine-candidate-trial-230117-5747129/</loc>
		<lastmod>2018-07-04T15:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-fast-tracks-review-of-pfizers-blood-cancer-drug-220217-5746186/</loc>
		<lastmod>2018-07-04T15:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc4bbviropharma_acquires_lev_pharmaceut/</loc>
		<lastmod>2018-07-04T15:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4b8scheringplough_q3_sal/</loc>
		<lastmod>2018-07-04T15:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f484eli_lilly_and_amylin_pharmaceuticals_sign_supply_agre/</loc>
		<lastmod>2018-07-04T15:41:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644b3pfizer_reports_surge_in_q3_net_i/</loc>
		<lastmod>2018-07-04T15:41:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/14493anadis_wins_approval_to_initiate_phase_iv_oral_hiv_therapy_/</loc>
		<lastmod>2018-07-04T15:41:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih-begins-phase-1-trial-of-mosquito-borne-disease-vaccine-candidate-ags-v-220217-5746223/</loc>
		<lastmod>2018-07-04T15:41:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abzena-signs-antibody-manufacturing-agreement-with-ucl-220217-5746246/</loc>
		<lastmod>2018-07-04T15:41:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european-commission-conditionally-approves-roches-cancer-drug-alecensa-220117-5745752/</loc>
		<lastmod>2018-07-04T15:41:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd48aavigens_phase_iib_spasticity_trial_fails_end/</loc>
		<lastmod>2018-07-04T15:41:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf4acsosei_and_aska_sign_commercialization_deal_for_oral_contrace/</loc>
		<lastmod>2018-07-04T15:41:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47489trius_therapeutics_wins_28_million_federal_con/</loc>
		<lastmod>2018-07-04T15:41:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4b2abbotts_humira_found_to_be_effective_against_crohns_di/</loc>
		<lastmod>2018-07-04T15:41:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5485american_oriental_bioengineering_acquires_nuo_hua_an/</loc>
		<lastmod>2018-07-04T15:41:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chi-med-commences-phase-2-trial-of-psc-candidate-savolitinib-210217-5744816/</loc>
		<lastmod>2018-07-04T15:41:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/modus-therapeutics-secures-sek32m-for-sevuparins-development-210217-5744806/</loc>
		<lastmod>2018-07-04T15:41:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf485chelsea_therapeutics_wins_dsmb_positive_review_for_phase_ii_arthritis_/</loc>
		<lastmod>2018-07-04T15:41:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f0494lct_wins_approval_to_initiate_phase_iiia_diabetes_trial_in_new_ze/</loc>
		<lastmod>2018-07-04T15:41:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/faron-doses-first-patent-in-traumakins-multi-organ-failure-study-210217-5744615/</loc>
		<lastmod>2018-07-04T15:41:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4aaalthea_technologies_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:41:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/794bfartes_medical_completes_enrollment_in_artefill_dermal_filler_/</loc>
		<lastmod>2018-07-04T15:41:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/61496alchemia_obtains_notice_of_allowance_for_key_fondaparinux_p/</loc>
		<lastmod>2018-07-04T15:41:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arix-bioscience-raises-100m-in-ipo-200217-5743653/</loc>
		<lastmod>2018-07-04T15:41:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/momenta-reveals-fda-warning-letter-to-contracted-glatopas-fillfinish-manufacturer-200217-5743598/</loc>
		<lastmod>2018-07-04T15:41:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec482perkinelmer_launches_gmp_radiosynthesis_ser/</loc>
		<lastmod>2018-07-04T15:41:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-arqules-tivantinib-fails-to-meet-primary-end-point-in-liver-cancer-study-200217-5743609/</loc>
		<lastmod>2018-07-04T15:41:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224a2q_therapeutics_and_johns_hopkins_university_collaborate_in_als_res/</loc>
		<lastmod>2018-07-04T15:41:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce4b2immunocellular_therapeutics_wins_two_new_patents_covering_cancer_trea/</loc>
		<lastmod>2018-07-04T15:41:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/50497life_recovery_systems_wins_nih_grant_to_study_expanded_use_of_thermosuit_s/</loc>
		<lastmod>2018-07-04T15:41:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614acariads_partner_merck_initiates_phase_ii_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:41:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-breast-cancer-drug-meets-primary-endpoint-in-phase-3-trial-170217-5742762/</loc>
		<lastmod>2018-07-04T15:41:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-secures-fda-approval-for-plaque-psoriasis-injection-170217-5742386/</loc>
		<lastmod>2018-07-04T15:41:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-acquires-ariad-pharmaceuticals-170217-5742363/</loc>
		<lastmod>2018-07-04T15:41:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9348bacurian_introduces_new_version_of_patient_recruitment_sof/</loc>
		<lastmod>2018-07-04T15:41:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5493javelin_pharmaceuticals_names_new_vice_president_of_clinical_res/</loc>
		<lastmod>2018-07-04T15:41:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc4a3concentric_medical_introduces_merci_distal_access_cat/</loc>
		<lastmod>2018-07-04T15:41:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-rheumatoid-arthritis-drug-shows-treatment-benefit-in-combination-but-not-alone-170217-5742191/</loc>
		<lastmod>2018-07-04T15:41:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-flynn-appeal-against-cmas-894m-fine-for-drug-price-hike-160217-5741229/</loc>
		<lastmod>2018-07-04T15:41:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/23482emergency_medical_services_acquires_templeton_rea/</loc>
		<lastmod>2018-07-04T15:41:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/874a8cardium_wins_fda_clearance_for_rapidblue_endovascular_s/</loc>
		<lastmod>2018-07-04T15:41:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/versant-ventures-forms-new-company-jecure-therapeutics-160217-5741270/</loc>
		<lastmod>2018-07-04T15:41:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824b53m_and_vaxinnate_partner_to_develop_flu_vaccine_/</loc>
		<lastmod>2018-07-04T15:41:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/07494teva_wins_fda_approval_for_fentanyl_transdermal_s/</loc>
		<lastmod>2018-07-04T15:41:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/x-chem-jannsen-expand-collaboration-on-inflammatory-disease-treatment-160217-5741251/</loc>
		<lastmod>2018-07-04T15:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ardelyx-met-primary-endpoint-in-tenapanors-study-to-treat-hyperphosphatemia-150217-5740927/</loc>
		<lastmod>2018-07-04T15:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-reports-positive-phase-3-results-for-two-drug-regimen-for-hiv-150217-5740091/</loc>
		<lastmod>2018-07-04T15:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c449dglades_pharmaceuticals_names_new_pres/</loc>
		<lastmod>2018-07-04T15:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/28492pfizer_and_ucb_form_new_company_to_speed_up_drug_discovery_pr/</loc>
		<lastmod>2018-07-04T15:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c0485raptor_initiates_dosing_in_phase_iia_nonalcoholic_steatohepatitis_/</loc>
		<lastmod>2018-07-04T15:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4banovartis_announces_corporate_restructuring_implements_key_initia/</loc>
		<lastmod>2018-07-04T15:41:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a74b5myriad_genetics_to_spin_off_drug_development_bus/</loc>
		<lastmod>2018-07-04T15:41:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/65489nanosyn_acquires_amphoras_assets_opens_first_branch_on_east_/</loc>
		<lastmod>2018-07-04T15:41:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c4b7nms_forms_new_antibody_drug_discovery_alliance_with_gene/</loc>
		<lastmod>2018-07-04T15:41:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizon-discovery-signs-master-service-agreement-with-leading-pharma-150217-5740069/</loc>
		<lastmod>2018-07-04T15:41:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-to-discontinue-verubecestats-alzheimers-disease-study-due-to-lack-of-efficacy-150217-5739786/</loc>
		<lastmod>2018-07-04T15:41:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novimmune-legochem-to-collaborate-on-antibody-drug-conjugate-research-5738989/</loc>
		<lastmod>2018-07-04T15:41:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7648elixte_biotechnology_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:41:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-to-close-japanese-research-subsidiary-140217-5739022/</loc>
		<lastmod>2018-07-04T15:41:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axovant-reports-positive-interim-results-from-investigational-drug-nelotanserins-study-140217-5738848/</loc>
		<lastmod>2018-07-04T15:41:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc4adtorreypines_therapeutics_initiates_dosing_in_phase_i_pain_/</loc>
		<lastmod>2018-07-04T15:41:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/254b3caridianbct_wins_ce_mark_for_expanded_treatment_range_of_mirasol_s/</loc>
		<lastmod>2018-07-04T15:41:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44b3amag_pharmaceuticals_obtains_fda_complete_response_letter_for_anemia/</loc>
		<lastmod>2018-07-04T15:41:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5349cgeron_initiates_enrollment_in_phase_i_myeloma_/</loc>
		<lastmod>2018-07-04T15:41:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4b4vertex_reports_positive_results_from_part_two_phase_iia_cystic_fibrosis_/</loc>
		<lastmod>2018-07-04T15:41:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-to-purchase-mead-johnson-for-166bn-130217-5737986/</loc>
		<lastmod>2018-07-04T15:41:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tracons-trc105-fails-to-meet-objective-in-phase-2-trial-in-recurrent-glioblastoma-130217-5737995/</loc>
		<lastmod>2018-07-04T15:41:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/german-pharma-stada-confirms-takeover-offer-from-two-companies-130217-5737942/</loc>
		<lastmod>2018-07-04T15:41:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/01498ardea_biosciences_wins_new_us_patent_for_hiv_trea/</loc>
		<lastmod>2018-07-04T15:41:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4b5digirad_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:41:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c9482basilea_pharmaceutica_wins_french_approval_for_eczema/</loc>
		<lastmod>2018-07-04T15:41:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a4a8novartis_to_acquire_nektars_pulmonary_business/</loc>
		<lastmod>2018-07-04T15:41:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174bds_bio_raises_26_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:41:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunomedics-seattle-genetics-sign-2bn-licencing-deal-for-experimental-cancer-drug-130217-5737726/</loc>
		<lastmod>2018-07-04T15:41:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-secure-stay-order-on-federal-courts-ruling-on-praulent-100217-5736944/</loc>
		<lastmod>2018-07-04T15:41:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jazz-enrolls-first-patient-in-jzp-110s-phase-2-trial-100217-5736984/</loc>
		<lastmod>2018-07-04T15:41:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc49ddepomed_initiates_enrollment_for_second_phase_iii_hot_flashes_/</loc>
		<lastmod>2018-07-04T15:41:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984bdsanofiaventis_expands_rd_operations_in_/</loc>
		<lastmod>2018-07-04T15:41:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a5491abbott_receives_fda_complete_response_letter_for_pain/</loc>
		<lastmod>2018-07-04T15:41:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec4b6novartis_q3_net_sal/</loc>
		<lastmod>2018-07-04T15:41:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84b6eli_lilly_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:41:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viking-reports-positive-initial-results-for-vk2809s-trial-in-gsd-100217-5736969/</loc>
		<lastmod>2018-07-04T15:41:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-consumer-healthcare-launches-new-otc-allergy-relief-product-in-us-100217-5736952/</loc>
		<lastmod>2018-07-04T15:41:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4249eaffymetrix_names_new_executive_vice_president_and_general_co/</loc>
		<lastmod>2018-07-04T15:41:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154a4neostem_obtains_800000_in_federal_fu/</loc>
		<lastmod>2018-07-04T15:41:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/marathon-pharmaceuticals-duchenne-muscular-dystrophy-drug-wins-fda-approval-100917-5736892/</loc>
		<lastmod>2018-07-04T15:41:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014aaillumina_introduces_genomestudio_data_analysis_sof/</loc>
		<lastmod>2018-07-04T15:41:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b486anticancers_diagnostics_unit_wins_fda_clearance_for_portable_homocysteine/</loc>
		<lastmod>2018-07-04T15:41:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e6491bg_medicine_names_new_vice_president_of_clinical_and_regulatory_af/</loc>
		<lastmod>2018-07-04T15:41:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/male-contraceptive-candidate-proves-efficacy-in-monkey-trial-090217-5735834/</loc>
		<lastmod>2018-07-04T15:41:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-not-to-hold-advisory-committee-meeting-for-portolas-betrixaban-090217-5735927/</loc>
		<lastmod>2018-07-04T15:41:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-updates-label-of-trulicity-to-include-use-in-type-2-diabetes-090217-5735904/</loc>
		<lastmod>2018-07-04T15:41:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3648badventrx_implements_corporate_restruct/</loc>
		<lastmod>2018-07-04T15:41:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81493avidas_pharmaceuticals_introduces_new_antiaging_pro/</loc>
		<lastmod>2018-07-04T15:41:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e6485ablynx_secures_new_facility_in_ghent_be/</loc>
		<lastmod>2018-07-04T15:41:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/41494t2_biosystems_names_new_vice_president_of_regulatory_and_qu/</loc>
		<lastmod>2018-07-04T15:41:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec499sucampo_pharmaceuticals_names_new_head_of_sales_and_mark/</loc>
		<lastmod>2018-07-04T15:41:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forbion-capital-invests-29m-in-prexton-therapeutics-090217-5735877/</loc>
		<lastmod>2018-07-04T15:41:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotech-companies-oppose-trumps-immigration-order-090217-5735762/</loc>
		<lastmod>2018-07-04T15:41:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ftc-files-lawsuit-on-shire-viropharma-for-blocking-generic-vancocin-080217-5734638/</loc>
		<lastmod>2018-07-04T15:41:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644bbipsen_completes_acquisition_of_te/</loc>
		<lastmod>2018-07-04T15:41:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c493cenerx_biopharma_raises_15_million_in_series_b_fina/</loc>
		<lastmod>2018-07-04T15:41:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/654adpharmaxis_wins_swiss_approval_to_market_airways_inflammation/</loc>
		<lastmod>2018-07-04T15:41:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b49bcohera_medical_raises_161_million_in_series_b_fina/</loc>
		<lastmod>2018-07-04T15:41:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb486cenerx_biopharma_initiates_phase_ii_study_of_depression/</loc>
		<lastmod>2018-07-04T15:41:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acticor-biotech-raises-15m-in-new-funding-080217-5734715/</loc>
		<lastmod>2018-07-04T15:41:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gw-pharmas-cannabis-derived-drug-shows-promise-in-brain-cancer-study-5734697/</loc>
		<lastmod>2018-07-04T15:41:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perrigo-files-for-fda-approval-for-generic-version-of-valeants-acne-gel-080717-5734682/</loc>
		<lastmod>2018-07-04T15:41:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51481endologix_wins_fda_approval_for_powerlink_xl_s/</loc>
		<lastmod>2018-07-04T15:41:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9489middlebrook_pharmaceuticals_names_new_vice_cha/</loc>
		<lastmod>2018-07-04T15:41:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/54494peregrine_completes_enrollment_in_first_stage_of_phase_ii_lung_cancer_/</loc>
		<lastmod>2018-07-04T15:41:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f948agenentech_to_continue_phase_iiicancer_/</loc>
		<lastmod>2018-07-04T15:41:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d94a8t2_biosystems_secures_108_million_in_fina/</loc>
		<lastmod>2018-07-04T15:41:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-secures-fda-approval-for-parsabiv-drug-to-treat-chronic-kidney-disease-5734542/</loc>
		<lastmod>2018-07-04T15:41:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ariad-seeks-european-approval-for-nsclc-drug-brigatinib-070217-5733511/</loc>
		<lastmod>2018-07-04T15:41:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/veeva-rolls-out-cloud-application-to-speed-up-regulatory-submission-delivery-070217-5733423/</loc>
		<lastmod>2018-07-04T15:41:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c483innovent_oncology_announces_first_agreement_between_rmcc_and_colorado/</loc>
		<lastmod>2018-07-04T15:41:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8749chp_and_home_dialysis_plus_sign_licensing_agre/</loc>
		<lastmod>2018-07-04T15:41:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964b2integreat_expands_partnership_with_nuance_communicati/</loc>
		<lastmod>2018-07-04T15:41:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384a5valeant_and_gsk_complete_collaboration_agreement_for_seizure/</loc>
		<lastmod>2018-07-04T15:41:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc485glycotex_finalizes_collaboration_agreement_with_advanced_medical_solu/</loc>
		<lastmod>2018-07-04T15:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunovaccines-immune-oncology-drug-enters-phase-2-trial-070217-5733410/</loc>
		<lastmod>2018-07-04T15:42:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chondrial-therapeutics-secures-226m-in-series-a-financing-070217-5733392/</loc>
		<lastmod>2018-07-04T15:42:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ergomeds-insomnia-drug-meets-primary-endpoint-in-phase-2-trial-070217-5733242/</loc>
		<lastmod>2018-07-04T15:42:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314acacceleron_pharma_initiates_phase_i_muscle_diseases_/</loc>
		<lastmod>2018-07-04T15:42:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f2499pfizer_settles_patent_litigation_involving_nsaid_pain_medica/</loc>
		<lastmod>2018-07-04T15:42:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de48ddaiichi_sankyo_acquires_525_stake_in_ra/</loc>
		<lastmod>2018-07-04T15:42:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/674adphase_forward_and_sgs_life_science_continue_partnership_in_phase_i_t/</loc>
		<lastmod>2018-07-04T15:42:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f24babiotel_names_new_evp_of_business_development_sales_and_mark/</loc>
		<lastmod>2018-07-04T15:42:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgens-repatha-reduces-risk-of-cardiovascular-events-in-fourier-outcomes-study-060217-5732256/</loc>
		<lastmod>2018-07-04T15:42:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-intellipharmaceutics-filing-of-nda-for-rexista-060217-5732234/</loc>
		<lastmod>2018-07-04T15:42:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/portola-enters-150m-royalty-agreement-with-healthcare-for-andexanet-alfa-060217-5732215/</loc>
		<lastmod>2018-07-04T15:42:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-mercks-sblas-for-keytruda-use-in-urothelial-cancer-060217-5732109/</loc>
		<lastmod>2018-07-04T15:42:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f2484cell_genesys_terminates_vital1_phase_iii_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:42:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9648brtog_and_us_oncology_partner_to_increase_patient_access_to_cancer_t/</loc>
		<lastmod>2018-07-04T15:42:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-proposes-to-buy-mead-johnson-for-167bn-030217-5731060/</loc>
		<lastmod>2018-07-04T15:42:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/soligenixs-sgx301-secures-pim-status-from-uk-mhra-to-treat-cutaneous-t-cell-lymphoma-030217-5731185/</loc>
		<lastmod>2018-07-04T15:42:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b1482exiqon_adopts_new_name_for_us_subsi/</loc>
		<lastmod>2018-07-04T15:42:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d488medimmune_establishes_new_rd_facility_in_cambridg/</loc>
		<lastmod>2018-07-04T15:42:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974a7micronics_completes_series_c_fina/</loc>
		<lastmod>2018-07-04T15:42:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tarveda-therapeutics-completes-30m-series-d-equity-financing-030217-5731167/</loc>
		<lastmod>2018-07-04T15:42:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sobi-secures-european-commission-approval-for-new-dosing-frequency-of-orfadin-030217-5731150/</loc>
		<lastmod>2018-07-04T15:42:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arven-selects-ge-healthcares-manufacturing-platform-to-expand-production-capacity-at-turkish-facility-5731133/</loc>
		<lastmod>2018-07-04T15:42:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7349dimdsoft_and_ergogroup_announce_framework_agreement_in_n/</loc>
		<lastmod>2018-07-04T15:42:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b499cheetah_medical_launches_new_hemodynamic_monitoring_product_in_e/</loc>
		<lastmod>2018-07-04T15:42:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/554b7lifecycle_pharma_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:42:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994b3crucell_and_aeras_initiate_phase_i_tuberculosis_vaccine_trial_in_/</loc>
		<lastmod>2018-07-04T15:42:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064b2meda_wins_approval_for_seasonal_allergic_rhinitis/</loc>
		<lastmod>2018-07-04T15:42:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-hepatitis-c-treatment-under-fda-priority-review-030217-5730894/</loc>
		<lastmod>2018-07-04T15:42:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/summit-details-next-stage-of-cdi-antibiotic-development-020217-5729777/</loc>
		<lastmod>2018-07-04T15:42:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abeona-enrolls-first-high-dose-subject-in-phase-12-gene-therapy-trial-for-abo-102-020217-5729983/</loc>
		<lastmod>2018-07-04T15:42:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4449fzygem_and_olympus_life_science_sign_collaboration_agre/</loc>
		<lastmod>2018-07-04T15:42:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent-initiates-phase-1b-trial-of-dengue-antiviral-candidate-020217-5729864/</loc>
		<lastmod>2018-07-04T15:42:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-clears-ind-application-of-audentess-crigler-najjar-syndrome-drug-020217-5729856/</loc>
		<lastmod>2018-07-04T15:42:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4bathe_medicines_company_reports_positive_data_from_myocardial_infarction_/</loc>
		<lastmod>2018-07-04T15:42:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a84a1lilly_introduces_new_forteo_delivery_device_/</loc>
		<lastmod>2018-07-04T15:42:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304bdinspire_gets_patent_for_allergy/</loc>
		<lastmod>2018-07-04T15:42:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-sanofis-xyzal-allergy-24hr-for-otc-use-020217-5729703/</loc>
		<lastmod>2018-07-04T15:42:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f849csound_surgical_forms_distribution_partnership_with_shippert_me/</loc>
		<lastmod>2018-07-04T15:42:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c482bolder_biotechnology_wins_16_million_nih_/</loc>
		<lastmod>2018-07-04T15:42:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d48focimum_biosolutions_wins_two_new_us_pa/</loc>
		<lastmod>2018-07-04T15:42:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db48areata_pharmaceuticals_wins_orphan_designation_for_pancreatic_cancer/</loc>
		<lastmod>2018-07-04T15:42:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e4484bk_medical_systems_and_amerinet_sign_new_threeyear_agre/</loc>
		<lastmod>2018-07-04T15:42:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe484cleveland_biolabs_doses_first_patient_in_radiation_injury_treatment_/</loc>
		<lastmod>2018-07-04T15:42:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844a3jennerex_completes_treatment_for_first_patient_cohort_in_phase_i_cancer_/</loc>
		<lastmod>2018-07-04T15:42:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a493catalent_pharma_gets_first_product_approval_for_syringe_facility_in_be/</loc>
		<lastmod>2018-07-04T15:42:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4649falexza_completes_enrollment_for_second_phase_iii_acute_agitation_/</loc>
		<lastmod>2018-07-04T15:42:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894a7miraculins_initiates_enrollment_in_second_prostate_cancer_stud/</loc>
		<lastmod>2018-07-04T15:42:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf4belpath_initiates_dosing_in_phase_i_amd_/</loc>
		<lastmod>2018-07-04T15:42:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/31480wuxi_pharmatech_expands_rd_services_collaboration_with_j/</loc>
		<lastmod>2018-07-04T15:42:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b4aapredictive_biosciences_raises_2175_million_in_fina/</loc>
		<lastmod>2018-07-04T15:42:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684abzila_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:42:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0849decho_therapeutics_wins_new_patent_for_symphony_glucose_monitoring_s/</loc>
		<lastmod>2018-07-04T15:42:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/19488intermune_announces_japanese_approval_of_pulmonary_fibrosis/</loc>
		<lastmod>2018-07-04T15:42:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b49cgenerex_initiates_enrollment_in_metformin_gum_/</loc>
		<lastmod>2018-07-04T15:42:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74admedimmune_licenses_reverse_genetics_technology_to_omni/</loc>
		<lastmod>2018-07-04T15:42:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/674b0philips_and_celsion_partner_in_cancer_res/</loc>
		<lastmod>2018-07-04T15:42:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5948fprognostix_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:42:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb485valeant_pharmaceuticals_acquires_coria_laborat/</loc>
		<lastmod>2018-07-04T15:42:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/38489abraxis_bioscience_wins_australian_approval_for_breast_cancer/</loc>
		<lastmod>2018-07-04T15:42:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf488ardea_biosciences_initiates_phase_iii_cancer_combination_therapy_/</loc>
		<lastmod>2018-07-04T15:42:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc489celgene_and_acceleron_initiate_phase_ii_myeloma_/</loc>
		<lastmod>2018-07-04T15:42:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4048epipex_pharmaceuticals_changes_name_to_adeona_pharmaceut/</loc>
		<lastmod>2018-07-04T15:42:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/404a3nellson_nutraceutical_signs_collaboration_agreement_with_ganeden_bi/</loc>
		<lastmod>2018-07-04T15:42:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2348fcorevalve_wins_patent_infringement_lawsuit_against_edwards_lifesci/</loc>
		<lastmod>2018-07-04T15:42:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf48fepigenomics_reports_positive_results_from_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:42:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/02492infinity_pharmaceuticals_initiates_phase_i_study_of_cancer/</loc>
		<lastmod>2018-07-04T15:42:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b484tomotherapy_signs_loi_with_hitachi_medi/</loc>
		<lastmod>2018-07-04T15:42:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/654bdprogenics_signs_licensing_agreement_with_ono_pharmaceu/</loc>
		<lastmod>2018-07-04T15:42:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a4a0ethicon_endosurgery_acquires_s/</loc>
		<lastmod>2018-07-04T15:42:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/034b2zimmer_holdings_completes_acquisition_of_abbott_/</loc>
		<lastmod>2018-07-04T15:42:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214b5abbott_laboratories_reports_increased_q3_/</loc>
		<lastmod>2018-07-04T15:42:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe480johnson__johnson_q3_sal/</loc>
		<lastmod>2018-07-04T15:42:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4a5roxane_launches_calcium_acetate_capsules_66/</loc>
		<lastmod>2018-07-04T15:42:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b1487astrazeneca_and_columbia_university_medical_center_form_collabor/</loc>
		<lastmod>2018-07-04T15:42:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/97491akorn_launches_topical_anesthetic_ophthalmic/</loc>
		<lastmod>2018-07-04T15:42:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e4b1cypress_wins_fda_approval_for_generic_allergy/</loc>
		<lastmod>2018-07-04T15:42:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244bbgenzyme_initiates_enrollment_for_postmarketing_fabry_disease_/</loc>
		<lastmod>2018-07-04T15:42:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314a8invitrogen_and_applied_biosystems_amend_merger_agre/</loc>
		<lastmod>2018-07-04T15:42:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de48dneopharm_signs_rd_agreement_with_/</loc>
		<lastmod>2018-07-04T15:42:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e74b8charles_river_opens_new_facility_in_shanghai_/</loc>
		<lastmod>2018-07-04T15:42:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824abchemocentryx_initiates_phase_i_gastrointestinal_diseases_tr/</loc>
		<lastmod>2018-07-04T15:42:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964aaproteus_biomedical_raises_32_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:42:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694bfavigen_initiates_opioid_withdrawal_/</loc>
		<lastmod>2018-07-04T15:42:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a49ebiomarin_reports_positive_results_from_phase_iia_sickle_cell_disease_tria/</loc>
		<lastmod>2018-07-04T15:42:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a8483inforsense_partners_with_gsk_to_enable_virtual_drug_disc/</loc>
		<lastmod>2018-07-04T15:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/03480miraculins_signs_licensing_agreement_with_mount_sinai_hos/</loc>
		<lastmod>2018-07-04T15:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/43493integra_lifesciences_wins_approval_to_market_accell_evo3_/</loc>
		<lastmod>2018-07-04T15:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a48cdelcath_systems_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/22492seattle_genetics_achieves_milestone_in_antibodydrug_collabor/</loc>
		<lastmod>2018-07-04T15:43:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c489eisai_wins_fda_approval_for_lymphoma/</loc>
		<lastmod>2018-07-04T15:43:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2d490methylgene_initiates_phase_i_fungal_infections_/</loc>
		<lastmod>2018-07-04T15:43:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384bblorus_therapeutics_receives_milestone_payment_from_zor_pharmaceut/</loc>
		<lastmod>2018-07-04T15:43:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d1499ziopharm_receives_eu_positive_opinion_for_sarcoma/</loc>
		<lastmod>2018-07-04T15:43:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4749camedica_wins_fda_clearance_for_seeplate_cervical_plate_s/</loc>
		<lastmod>2018-07-04T15:43:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6449cgsk_to_acquire_egyptian_mature_products_business_of_bristol_myers_s/</loc>
		<lastmod>2018-07-04T15:43:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a84a1basilea_wins_finnish_marketing_approval_for_eczema_d/</loc>
		<lastmod>2018-07-04T15:43:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84bbivax_diagnostics_names_new_board_me/</loc>
		<lastmod>2018-07-04T15:43:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/574b1titan_medical_completes_phase_b_prototype_of_amadeus_robotic_surgical_s/</loc>
		<lastmod>2018-07-04T15:43:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e84a6neumirrx_wins_new_us_patent_for_drug_formulation_techn/</loc>
		<lastmod>2018-07-04T15:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/42492us_court_upholds_bayer_barr_agreement_over_generic/</loc>
		<lastmod>2018-07-04T15:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9948bbayer_obtains_market_clearance_for_new_oral_contraceptive_in_e/</loc>
		<lastmod>2018-07-04T15:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d4bfmedtronic_launches_xstop_peek_ipd_s/</loc>
		<lastmod>2018-07-04T15:43:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b4b5athersys_initiates_patient_dosing_in_phase_i_acute_myocardial_infarction_/</loc>
		<lastmod>2018-07-04T15:43:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b49cdiakine_therapeutics_advances_diabetes_drug_into_phase_ii_/</loc>
		<lastmod>2018-07-04T15:43:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e4b9sirion_therapeutics_reports_positive_results_from_uveitis_/</loc>
		<lastmod>2018-07-04T15:43:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8748apar_pharmaceutical_resizes_generic/</loc>
		<lastmod>2018-07-04T15:43:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd491covidien_introduces_parietex_progrip_hernia_repair/</loc>
		<lastmod>2018-07-04T15:43:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e493life_spine_launches_mew_thoracolumbar_pedicle_screw_s/</loc>
		<lastmod>2018-07-04T15:43:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spero-therapeutics-acquires-antibacterial-candidates-from-pro-bono-bio-010217-5728878/</loc>
		<lastmod>2018-07-04T15:43:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ibm-seeks-publics-help-to-find-new-cancer-cures-010217-5728865/</loc>
		<lastmod>2018-07-04T15:43:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/motif-bio-reaches-milestone-in-antibiotic-trial-010217-5728852/</loc>
		<lastmod>2018-07-04T15:43:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd499cook_medical_introduces_new_tissue_repair_sol/</loc>
		<lastmod>2018-07-04T15:43:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44adscientx_announces_relocation_/</loc>
		<lastmod>2018-07-04T15:43:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d489alcon_signs_two_agreements_to_expand_drug_port/</loc>
		<lastmod>2018-07-04T15:43:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4b9joimax_names_new_pres/</loc>
		<lastmod>2018-07-04T15:43:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/25495immunomedics_wins_new_us_pa/</loc>
		<lastmod>2018-07-04T15:43:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heptares-university-of-cambridge-to-jointly-research-on-apelin-receptor-010217-5728757/</loc>
		<lastmod>2018-07-04T15:43:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eu-approves-novartis-votubia-to-treat-seizures-in-tsc-patients-010217-5728587/</loc>
		<lastmod>2018-07-04T15:43:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-court-of-appeals-affirms-cumberlands-victory-in-patent-litigation-case-310117-5727800/</loc>
		<lastmod>2018-07-04T15:43:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db49fmirixa_signs_licensing_and_consulting_agreement_with_pharmacy_/</loc>
		<lastmod>2018-07-04T15:43:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/67495wuxi_pharmatech_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:43:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b4bdtianyin_to_launch_azithromycin_dispersible_ta/</loc>
		<lastmod>2018-07-04T15:43:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d4b3addex_completes_first_part_of_phase_i_levodopa_associated_dyskinesia_/</loc>
		<lastmod>2018-07-04T15:43:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5349emilestone_scientific_names_ne/</loc>
		<lastmod>2018-07-04T15:43:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eyegate-reveals-positive-results-from-human-pilot-trial-of-ocular-bandage-gel-310117-5727596/</loc>
		<lastmod>2018-07-04T15:43:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurotrope-stanford-university-to-accelerate-synthesis-of-alzheimers-drug-310117-5727652/</loc>
		<lastmod>2018-07-04T15:43:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferring-enteris-to-develop-oral-formulation-of-peptide-derived-injectable-therapeutic-310117-5727637/</loc>
		<lastmod>2018-07-04T15:43:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/674b4synta_receives_25_million_milestone_payment_from_glaxosmith/</loc>
		<lastmod>2018-07-04T15:43:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7749eikonisys_reports_positive_results_from_cancer_detection_/</loc>
		<lastmod>2018-07-04T15:43:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd49bintegra_lifesciences_to_market_theken_products_under_integra_spine_/</loc>
		<lastmod>2018-07-04T15:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/204b6par_pharmaceuticals_coo_re/</loc>
		<lastmod>2018-07-04T15:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734balilly_commences_cash_tender_offer_for_imclone_sy/</loc>
		<lastmod>2018-07-04T15:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-label-update-to-allergans-avycaz-310117-5727548/</loc>
		<lastmod>2018-07-04T15:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-recommends-approval-of-amgens-adalimumab-biosimilar-300117-5726483/</loc>
		<lastmod>2018-07-04T15:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kainos-medicine-starts-phase-1-trials-of-parkinsons-disease-drug-candidate-300117-5726579/</loc>
		<lastmod>2018-07-04T15:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e48arf_surgical_systems_wins_approval_to_market_blairport/</loc>
		<lastmod>2018-07-04T15:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/364b4coda_genomics_and_genencor_sign_collaboration_agre/</loc>
		<lastmod>2018-07-04T15:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db492vertiflex_names_new_vice_president_of_international_/</loc>
		<lastmod>2018-07-04T15:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aurinia-selects-worldwide-clinical-trials-as-cro-for-phase-3-lupus-nephritis-study-300117-5726574/</loc>
		<lastmod>2018-07-04T15:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biscayne-neurotherapeutics-raises-3m-for-antiepileptic-compound-300117-5726560/</loc>
		<lastmod>2018-07-04T15:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/emas-chmp-backs-pfizers-xeljanz-for-rheumatoid-arthritis-300117-5726409/</loc>
		<lastmod>2018-07-04T15:43:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094aeeragen_names_inter_medico_as_canadian_distri/</loc>
		<lastmod>2018-07-04T15:43:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9448abiopharmetics_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:43:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf48ecarl_zeiss_meditec_and_optovue_settle_di/</loc>
		<lastmod>2018-07-04T15:43:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f7498nile_therapeutics_reports_positive_interim_data_from_heart_failure_/</loc>
		<lastmod>2018-07-04T15:43:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/cellestia-biotech-raises-chf8m-seed-financing-270716-5725480/</loc>
		<lastmod>2018-07-04T15:43:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/celgene-to-buy-biotechnology-company-delinia-270717-5725470/</loc>
		<lastmod>2018-07-04T15:43:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-72-mcg-dose-of-linzess-for-adults-with-chronic-idiopathic-constipation-270117-5725459/</loc>
		<lastmod>2018-07-04T15:43:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c54a3orthomems_names_ne/</loc>
		<lastmod>2018-07-04T15:43:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/46495neurogen_reports_positive_results_from_phase_ii_rls_and_parkinsons_t/</loc>
		<lastmod>2018-07-04T15:43:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/044b0response_biomedical_to_secure_55_million_in_fina/</loc>
		<lastmod>2018-07-04T15:43:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114bdcell_therapeuticss_combination_therapy_found_effective_against_lym/</loc>
		<lastmod>2018-07-04T15:43:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-results-for-c-difficile-vaccine-candidate-in-phase-2-study-270117-5725378/</loc>
		<lastmod>2018-07-04T15:43:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-buy-actelion-for-30bn-270117-5725223/</loc>
		<lastmod>2018-07-04T15:43:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/eisais-liver-cancer-drug-lenvima-succeeds-in-phase-3-trial-260117-5724789/</loc>
		<lastmod>2018-07-04T15:43:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/514a7st_jude_medical_wins_approval_for_angioseal_vascular_closure_d/</loc>
		<lastmod>2018-07-04T15:43:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/72490axial_biotech_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:43:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264aeamdl_announces_corporate_restruct/</loc>
		<lastmod>2018-07-04T15:43:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4a7rxi_licenses_rnai_delivery_technology_from/</loc>
		<lastmod>2018-07-04T15:43:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984bekinetic_concepts_wins_fda_clearance_for_tissue_repair_pr/</loc>
		<lastmod>2018-07-04T15:43:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck-ibm-watson-health-partner-for-neurological-and-psychiatric-drug-discovery-260117-5724786/</loc>
		<lastmod>2018-07-04T15:43:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-mulls-options-including-ipo-spinoff-for-alcon-eye-care-unit-260117-5724780/</loc>
		<lastmod>2018-07-04T15:43:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9849eavi_biopharma_receives_eu_positive_opinion_for_muscular_dystrophy/</loc>
		<lastmod>2018-07-04T15:43:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/66480insmed_to_initiate_phase_i_study_for_fob_version_of_neutropenia/</loc>
		<lastmod>2018-07-04T15:43:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/discuva-secures-innovate-uk-grant-for-new-antibiotics-development-250117-5724375/</loc>
		<lastmod>2018-07-04T15:43:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e4b3abraxis_bioscience_names_new_executive_vice_president_of_opera/</loc>
		<lastmod>2018-07-04T15:43:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6490northstar_neuroscience_wins_approval_for_major_depressive_disorder_/</loc>
		<lastmod>2018-07-04T15:43:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/324abhemcon_medical_completes_fungal_nail_infection_/</loc>
		<lastmod>2018-07-04T15:43:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/connect-secures-25m-financing-to-advance-immune-modulators-clinical-development-250117-5724387/</loc>
		<lastmod>2018-07-04T15:43:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onxeo-ends-patient-enrollment-for-phase-3-trial-of-hcc-drug-livatag-250117-5723883/</loc>
		<lastmod>2018-07-04T15:43:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cue-biopharma-secures-26m-in-invested-private-capital-250117-5724043/</loc>
		<lastmod>2018-07-04T15:43:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c94aforexigen_receives_notice_of_allowance_for_fourth_us_patent_on_obesity/</loc>
		<lastmod>2018-07-04T15:43:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4a1neuralstem_licenses_spinal_cord_injection_technology_from_cleveland_c/</loc>
		<lastmod>2018-07-04T15:43:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4adsurface_logix_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:43:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4a6avidas_acquires_rights_to_crown_laboratoriess_dermatology_pro/</loc>
		<lastmod>2018-07-04T15:43:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/88489regado_completes_enrollment_in_phase_iia_study_of_anticoagulation_s/</loc>
		<lastmod>2018-07-04T15:43:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elc-and-psr-group-to-partner-on-advanced-drug-development-250117-5724031/</loc>
		<lastmod>2018-07-04T15:43:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intrexon-to-acquire-gene-delivery-technology-firm-genvec-250117-5724014/</loc>
		<lastmod>2018-07-04T15:43:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/abbvies-hepatitis-c-treatment-under-accelerated-review-by-ema-250117-5723833/</loc>
		<lastmod>2018-07-04T15:43:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b4482aradigm_completes_enrollment_in_phase_ii_bronchiectasis_/</loc>
		<lastmod>2018-07-04T15:43:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a4a1promius_pharma_introduces_atopic_dermatitis_pr/</loc>
		<lastmod>2018-07-04T15:43:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/74496aethlon_medical_completes_human_safety_study_of_hemopur/</loc>
		<lastmod>2018-07-04T15:43:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/62486omrix_wins_eu_approval_for_liquid_fibrin_se/</loc>
		<lastmod>2018-07-04T15:43:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b481radi_and_ge_healthcare_to_integrate_pressurewire_aeris_and_ffr_in_ge_macl/</loc>
		<lastmod>2018-07-04T15:43:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelions-pah-drug-macitentan-fails-to-meet-primary-objective-in-phase-3-trial-240117-5722863/</loc>
		<lastmod>2018-07-04T15:43:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-domain-therapeutics-partner-to-co-develop-adenosine-receptor-antagonists-240117-5722950/</loc>
		<lastmod>2018-07-04T15:43:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-gives-nod-to-human-trial-for-nantkwests-natural-killer-cell-therapy-240117-5722889/</loc>
		<lastmod>2018-07-04T15:43:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/044a5ge_healthcare_introduces_discovery_petc/</loc>
		<lastmod>2018-07-04T15:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104a1hospira_acquires_endotool_business_from_md_scien/</loc>
		<lastmod>2018-07-04T15:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c9489pharmathene_secures_131_million_in_equity_financing_from_panacea_b/</loc>
		<lastmod>2018-07-04T15:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/concerts-cystic-fibrosis-candidate-gets-odd-from-fda-230117-5721486/</loc>
		<lastmod>2018-07-04T15:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544abadvanced_circulatory_systems_secures_additional_15_million_fro/</loc>
		<lastmod>2018-07-04T15:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124baabio_pharma_names_ne/</loc>
		<lastmod>2018-07-04T15:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european-medicines-agency-accepst-to-review-novelions-maa-for-metreleptin-240117-5722907/</loc>
		<lastmod>2018-07-04T15:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/immune-pharmaceuticals-enters-research-collaboration-to-antibodies-in-cancer-240117-5722623/</loc>
		<lastmod>2018-07-04T15:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncomed-begins-enrollment-of-brontictuzumab-phase-1-trial-230117-5721525/</loc>
		<lastmod>2018-07-04T15:44:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6549bsidmap_introduces_new_metabolomics_service_for_detection_of_tox/</loc>
		<lastmod>2018-07-04T15:44:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b498pioneer_surgical_technology_signs_distribution_agreement_with_swemacim/</loc>
		<lastmod>2018-07-04T15:44:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/35482miramar_labs_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:44:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/da495neuronascent_obtains_multiple_funding_for_neurogenesis_drug_pro/</loc>
		<lastmod>2018-07-04T15:44:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/abzena-enters-into-licensing-agreement-for-thiobridge-230117-5721514/</loc>
		<lastmod>2018-07-04T15:44:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ema-validates-gileads-chronic-hepatitis-c-regimen-230117-5721592/</loc>
		<lastmod>2018-07-04T15:44:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/764aemmrc_initiates_phase_ib_multiple_myeloma_/</loc>
		<lastmod>2018-07-04T15:44:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-bristol-myers-and-ono-pharmaceutical-agree-to-settle-keytruda-patent-suit-230117-5721470/</loc>
		<lastmod>2018-07-04T15:44:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/cytori-to-buy-azayas-nanoparticle-development-platform-200117-5720746/</loc>
		<lastmod>2018-07-04T15:44:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/otonomy-starts-patient-enrollment-in-phase-2-trial-of-oto-104-190117-5720359/</loc>
		<lastmod>2018-07-04T15:44:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a9482aperio_wins_patent_for_use_of_tdi_arrays_in_microscope_slide_sca/</loc>
		<lastmod>2018-07-04T15:44:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e49bglide_pharma_secures_additional_gbp22_million_in_fu/</loc>
		<lastmod>2018-07-04T15:44:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a49bcydex_pharmaceuticals_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:44:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c74afakorn_signs_commercial_manufacturing_supply_agre/</loc>
		<lastmod>2018-07-04T15:44:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce4b2atcor_medical_signs_new_supply_con/</loc>
		<lastmod>2018-07-04T15:44:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ethypharm-agrees-to-acquire-uk-based-martindale-pharma-190117-5720365/</loc>
		<lastmod>2018-07-04T15:44:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abeona-gets-orphan-drug-status-in-eu-for-abo-101-gene-therapy-in-sanfilippo-syndrome-type-b-190117-5720371/</loc>
		<lastmod>2018-07-04T15:44:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-imbruvica-for-relapsedrefractory-marginal-zone-lymphoma-190117-5720541/</loc>
		<lastmod>2018-07-04T15:44:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e499tb_alliance_and_sanofiaventis_partner_for_tb_drug_res/</loc>
		<lastmod>2018-07-04T15:44:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4acpharming_group_names_ne/</loc>
		<lastmod>2018-07-04T15:44:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e486lev_pharmaceuticals_wins_approval_for_angioedema/</loc>
		<lastmod>2018-07-04T15:44:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef493cardima_renews_marketing_contract_with_bi/</loc>
		<lastmod>2018-07-04T15:44:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d2496pioneer_surgical_and_bonovo_orthopedics_sign_distribution_agre/</loc>
		<lastmod>2018-07-04T15:44:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/prometics-alstrom-syndrome-treatment-gets-orphan-drug-status-in-europe-190117-5720084/</loc>
		<lastmod>2018-07-04T15:44:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atyr-pharmas-resolaris-secures-fda-fast-track-status-190117-5720065/</loc>
		<lastmod>2018-07-04T15:44:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mallinckrodt-to-pay-100m-to-settle-ftc-state-charges-to-resolve-questcor-issue-190117-5719937/</loc>
		<lastmod>2018-07-04T15:44:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8349aheritage_pharmaceuticals_launches_generic_inderal_ta/</loc>
		<lastmod>2018-07-04T15:44:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-ovid-to-jointly-develop-and-commercialize-tak-935-190117-5719988/</loc>
		<lastmod>2018-07-04T15:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringers-humira-biosimilar-to-be-reviewed-by-ema-and-fda-190117-5719975/</loc>
		<lastmod>2018-07-04T15:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-to-buy-colucid-pharmaceuticals-for-960m-190117-5719897/</loc>
		<lastmod>2018-07-04T15:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4a3ranbaxy_files_ind_application_for_respiratory_inflammation_cand/</loc>
		<lastmod>2018-07-04T15:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3148dsynageva_biopharma_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/344a7invitrogen_introduces_new_automated_cell_counting_instr/</loc>
		<lastmod>2018-07-04T15:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a4abmercks_rotavirus_vaccine_awarded_who_prequalification_s/</loc>
		<lastmod>2018-07-04T15:44:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european-commission-approves-suliqua-to-treat-adults-with-type-2-diabetes-180117-5718981/</loc>
		<lastmod>2018-07-04T15:44:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-to-pay-125bn-to-forward-on-settlement-and-licensing-of-ms-drug-180117-5718898/</loc>
		<lastmod>2018-07-04T15:44:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea4b4elixir_medical_signs_licensing_agreement_with_nov/</loc>
		<lastmod>2018-07-04T15:44:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinigen-begins-managed-access-program-for-tesaros-ovarian-cancer-drug-niraparib-180117-5718923/</loc>
		<lastmod>2018-07-04T15:44:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/00487gene_logic_and_desciner_partner_to_create_genomics_ga/</loc>
		<lastmod>2018-07-04T15:44:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d0480gore_obtains_fda_approval_for_clinical_study_of_embolic_f/</loc>
		<lastmod>2018-07-04T15:44:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4a7astrazeneca_wins_fda_approval_for_new_bipolar_disorder/</loc>
		<lastmod>2018-07-04T15:44:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c14a2medicis_receives_fda_approval_of_pma_supplement_for_wrinkle_treatment/</loc>
		<lastmod>2018-07-04T15:44:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evgens-breast-cancer-phase-ii-trial-doses-first-patient-180117-5718911/</loc>
		<lastmod>2018-07-04T15:44:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-refines-endpoints-in-immuno-oncology-trials-for-nsclc-180117-5718798/</loc>
		<lastmod>2018-07-04T15:44:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/monosol-rx-files-patent-infringement-case-against-biodelivery-sciences-international-170717-5717996/</loc>
		<lastmod>2018-07-04T15:44:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b5486dr_willmar_schwabe_pharmaceuticals_to_acquire_enzymatic_th/</loc>
		<lastmod>2018-07-04T15:44:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4b7excaliard_pharmaceuticals_announces_key_management_ch/</loc>
		<lastmod>2018-07-04T15:44:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4aftrireme_medical_wins_ce_marking_for_antares_coronary_stent_s/</loc>
		<lastmod>2018-07-04T15:44:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c4bbcyto_pulse_sciences_announces_approval_for_phase_iii_dna_vaccine_/</loc>
		<lastmod>2018-07-04T15:44:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b34b1angiotechs_partner_boston_scientific_wins_approval_for_taxus_liberte_/</loc>
		<lastmod>2018-07-04T15:44:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/05484santhera_launches_friedreichs_ataxia/</loc>
		<lastmod>2018-07-04T15:44:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b493bayer_wins_fda_approval_for_hemophilia/</loc>
		<lastmod>2018-07-04T15:44:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3f48bkamada_presents_positive_data_from_phase_ii_cystic_fibrosis_/</loc>
		<lastmod>2018-07-04T15:44:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684bdtripos_signs_collaboration_agreement_with_astraz/</loc>
		<lastmod>2018-07-04T15:44:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0548dakorn_wins_fda_approval_for_akten_ophthalmic_gel/</loc>
		<lastmod>2018-07-04T15:44:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizon-discovery-broadens-gene-editing-capabilities-170117-5717985/</loc>
		<lastmod>2018-07-04T15:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chi-med-starts-phase-ii-study-of-sulfatinib-in-second-line-biliary-tract-cancer-in-china-170117-5717971/</loc>
		<lastmod>2018-07-04T15:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/malin-buys-33-interest-in-uk-based-wren-therapeutics-170117-5717899/</loc>
		<lastmod>2018-07-04T15:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c4adcenomed_and_torreypines_sign_licensing_agreem/</loc>
		<lastmod>2018-07-04T15:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824a2neotropix_initiates_enrollment_for_neuroendocrine_cancer_/</loc>
		<lastmod>2018-07-04T15:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0349amoraga_biotechnology_signs_licensing_agreement_with_pharma/</loc>
		<lastmod>2018-07-04T15:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54a3sinobiomed_names_ne/</loc>
		<lastmod>2018-07-04T15:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/83484epicept_granted_european_marketing_approval_for_leukemia/</loc>
		<lastmod>2018-07-04T15:44:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scottish-medicines-consortium-approves-zepatier-to-treat-chronic-hepatitis-c-5717739/</loc>
		<lastmod>2018-07-04T15:44:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/aptevo-therapeutics-receives-20m-payment-from-emergent-biosolutions-160117-5717004/</loc>
		<lastmod>2018-07-04T15:44:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/obseva-completes-phase-1-first-in-women-study-of-obe022-to-treat-preterm-labor-160117-5716994/</loc>
		<lastmod>2018-07-04T15:44:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f248bwatson_reports_positive_results_from_overactive_bladder_/</loc>
		<lastmod>2018-07-04T15:44:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/934a4nmt_medical_completes_enrollment_for_pfostroke_/</loc>
		<lastmod>2018-07-04T15:44:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e4a7calistoga_pharmaceuticals_names_ne/</loc>
		<lastmod>2018-07-04T15:44:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14a2luminex_wins_canadian_approval_for_xtag_respiratory_viral_pa/</loc>
		<lastmod>2018-07-04T15:44:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a488chembio_wins_fda_approval_for_extended_age_range_for_hiv_rapid_/</loc>
		<lastmod>2018-07-04T15:44:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc4acxcorporeal_names_new_chairman_an/</loc>
		<lastmod>2018-07-04T15:44:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884abboston_scientific_completes_enrollment_for_taxus_element_stent_/</loc>
		<lastmod>2018-07-04T15:44:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a9486no_cold_medicines_for_kids_under_four_say_pharma_/</loc>
		<lastmod>2018-07-04T15:44:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e483biogen_idecs_phase_ii_rheumatoid_arthritis_trial_fails_end/</loc>
		<lastmod>2018-07-04T15:44:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b34adalkermes_announces_fda_approval_of_new_injection_site_for_risperdal_c/</loc>
		<lastmod>2018-07-04T15:44:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nivalis-therapeutics-unveils-corporate-restructuring-160117-5716979/</loc>
		<lastmod>2018-07-04T15:44:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rheumatoid-arthritis-candidate-baricitinibs-nda-review-period-extended-by-fda-160117-5716828/</loc>
		<lastmod>2018-07-04T15:44:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunovions-dasotraline-improves-adhd-symptoms-in-children-in-phase-23-study-160117-5716733/</loc>
		<lastmod>2018-07-04T15:44:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c48broche_nimblegen_introduces_new_cgh_a/</loc>
		<lastmod>2018-07-04T15:44:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84b3pathway_medical_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:44:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144b6johnson__johnson_names_new_worldwide_chairman_of_pharmaceuticals_/</loc>
		<lastmod>2018-07-04T15:44:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce48dnatus_medical_to_acquire_certain_assets_from_brainz_instru/</loc>
		<lastmod>2018-07-04T15:44:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heron-submits-nda-for-cinv-candidate-cinvanti-to-fda-130117-5716137/</loc>
		<lastmod>2018-07-04T15:44:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncoimmune-secures-15m-in-series-a-funding-round-130117-5716102/</loc>
		<lastmod>2018-07-04T15:44:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9480sagent_and_icf_sign_development_and_supply_collaboration_agre/</loc>
		<lastmod>2018-07-04T15:44:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/redhills-ntm-drug-rhb-104-gets-qidp-fast-track-designation-from-fda-130117-5716060/</loc>
		<lastmod>2018-07-04T15:44:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524ablumen_wins_fda_clearance_for_lbi_embolectomy_s/</loc>
		<lastmod>2018-07-04T15:44:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4a1scolr_pharma_completes_enrollment_and_dosing_in_ibuprofen_er_/</loc>
		<lastmod>2018-07-04T15:44:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd4beorthoscan_raises_75_million_in_fina/</loc>
		<lastmod>2018-07-04T15:44:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6484intelgenx_and_cary_to_file_nda_for_antidepre/</loc>
		<lastmod>2018-07-04T15:44:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb493icagen_initiates_phase_ii_allergic_asthma_/</loc>
		<lastmod>2018-07-04T15:44:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474b3abbott_opens_new_research_facility_and_pilot_plant_in_ge/</loc>
		<lastmod>2018-07-04T15:44:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd4a4imuc_files_patent_application_for_cancer_stem_cell_vaccine_techn/</loc>
		<lastmod>2018-07-04T15:44:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/85480averion_opens_new_office_in_czech_rep/</loc>
		<lastmod>2018-07-04T15:44:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b48dcovidien_launches_new_biologic_im/</loc>
		<lastmod>2018-07-04T15:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/25499biowa_licenses_potelligent_technology_t/</loc>
		<lastmod>2018-07-04T15:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphosys-partner-to-commence-phase-2-trial-of-bimagrumab-130117-5716082/</loc>
		<lastmod>2018-07-04T15:45:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-appeals-court-upholds-eli-lillys-patent-on-alimta-cancer-drug-130117-5716035/</loc>
		<lastmod>2018-07-04T15:45:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-strikes-licensing-deal-with-vertex-on-cancer-rd-programs-120117-5714826/</loc>
		<lastmod>2018-07-04T15:45:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74bacircassia_acquires_commercialization_rights_to_dopexamine_from_/</loc>
		<lastmod>2018-07-04T15:45:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904b3horizon_therapeutics_names_ne/</loc>
		<lastmod>2018-07-04T15:45:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/784bfqlt_initiates_phase_i_safety_study_of_synthetic_retinoid/</loc>
		<lastmod>2018-07-04T15:45:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4a4apieron_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:45:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea492evotec_initiates_phase_i_clinical_studies_of_antiinflammatory/</loc>
		<lastmod>2018-07-04T15:45:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/visterra-doses-first-patient-in-phase-2a-trial-of-influenza-a-candidate-vis410-120117-5714936/</loc>
		<lastmod>2018-07-04T15:45:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-gets-european-approval-for-hepatitis-b-candidate-vemlidy-120117-5714958/</loc>
		<lastmod>2018-07-04T15:45:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-for-sangamos-sb-318-to-treat-mps-i-120117-5714864/</loc>
		<lastmod>2018-07-04T15:45:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/fda-to-review-biocon-and-mylans-biosimilar-drug-for-breast-cancer-120117-5714736/</loc>
		<lastmod>2018-07-04T15:45:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valirxs-prostate-cancer-drug-val201-records-positive-results-in-low-dose-trial-110117-5714142/</loc>
		<lastmod>2018-07-04T15:45:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/debiopharm-unveils-positive-phase-2-trial-with-debio-1450-in-absssi-patients-110117-5714055/</loc>
		<lastmod>2018-07-04T15:45:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/16498watson_wins_fda_approval_for_benign_prostatic_hyperplasia/</loc>
		<lastmod>2018-07-04T15:45:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/44484shionogi_acquires_sciele_p/</loc>
		<lastmod>2018-07-04T15:45:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e4bcinspire_pharmaceuticals_initiates_phase_i_glaucoma_/</loc>
		<lastmod>2018-07-04T15:45:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4b8endosense_initiates_atrial_arrhythmias_study/</loc>
		<lastmod>2018-07-04T15:45:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/764b3roche_reports_encouraging_results_from_phase_iii_leukemia_/</loc>
		<lastmod>2018-07-04T15:45:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-awards-more-than-22m-in-grants-to-support-hiv-cure-research-110117-5714044/</loc>
		<lastmod>2018-07-04T15:45:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-mercks-application-for-lung-cancer-combo-therapy-5714026/</loc>
		<lastmod>2018-07-04T15:45:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-pharmaceuticals-agrees-to-divest-21bn-in-assets-110117-5713925/</loc>
		<lastmod>2018-07-04T15:45:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81499charter_medical_wins_fda_approval_for_cryogenic_storage_conta/</loc>
		<lastmod>2018-07-04T15:45:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f4afalphatec_introduces_new_profuse_bone_sca/</loc>
		<lastmod>2018-07-04T15:45:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a8499ironwood_and_forest_report_positive_results_from_phase_iib_ibsc_/</loc>
		<lastmod>2018-07-04T15:45:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e492ardea_reports_encouraging_preclinical_data_from_antiinflammatory_drug_/</loc>
		<lastmod>2018-07-04T15:45:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4848dmarinus_completes_two_phase_ii_milestones_in_epilepsy_drug_pr/</loc>
		<lastmod>2018-07-04T15:45:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-egalets-opioid-prescription-painkiller-100117-5713116/</loc>
		<lastmod>2018-07-04T15:45:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zebra-biologics-to-partner-with-abbvie-on-new-antibody-therapeutics-discovery-100117-5712961/</loc>
		<lastmod>2018-07-04T15:45:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen-to-buy-merrimacks-global-oncology-assets-100117-5712930/</loc>
		<lastmod>2018-07-04T15:45:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be491nccn_abraxis_bioscience_and_astrazeneca_form_anticancer_collabor/</loc>
		<lastmod>2018-07-04T15:45:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b4b1reliant_technologies_wins_fda_approval_for_new_fraxel_laser_handp/</loc>
		<lastmod>2018-07-04T15:45:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4449blilly_resolves_multistate_investigation_of_zy/</loc>
		<lastmod>2018-07-04T15:45:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34bamedelis_establishes_new_european_division_appoints_n/</loc>
		<lastmod>2018-07-04T15:45:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4b9arbios_sells_bioartificial_liver_system_to_hepalife_technol/</loc>
		<lastmod>2018-07-04T15:45:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cumberland-pharmaceuticals-clinigen-sign-us-commercialization-deal-for-totect-100117-5712914/</loc>
		<lastmod>2018-07-04T15:45:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/silence-therapeutics-acquires-minority-stake-in-arrowhead-pharmaceuticals-100117-5712898/</loc>
		<lastmod>2018-07-04T15:45:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-to-buy-ariad-pharmaceuticals-for-52bn-100117-5712789/</loc>
		<lastmod>2018-07-04T15:45:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15489hairdx_to_initiate_clinical_study_of_genetic_therapy_for_female_bal/</loc>
		<lastmod>2018-07-04T15:45:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a8480millipore_opens_new_facility_in_ir/</loc>
		<lastmod>2018-07-04T15:45:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4049abridge_laboratories_wins_contract_from/</loc>
		<lastmod>2018-07-04T15:45:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f949cmannatech_introduces_new_fatloss_pr/</loc>
		<lastmod>2018-07-04T15:45:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4b1great_basin_scientific_secures_39_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:45:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mast-therapeutics-and-savara-sign-merger-deal-090117-5711876/</loc>
		<lastmod>2018-07-04T15:45:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-to-appeal-courts-ruling-in-praulent-patent-case-090117-5711664/</loc>
		<lastmod>2018-07-04T15:45:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentechs-lucentis-approved-by-fda-for-treating-myopic-choroidal-neovascularization-090117-5711800/</loc>
		<lastmod>2018-07-04T15:45:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f48abiomarin_establishes_new_office_in_brisbane_calif/</loc>
		<lastmod>2018-07-04T15:45:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-secures-odd-status-for-alxn1210-from-fda-090117-5711785/</loc>
		<lastmod>2018-07-04T15:45:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca492castle_biosciences_signs_option_agreement_with_md_anderson_cancer_c/</loc>
		<lastmod>2018-07-04T15:45:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/37497huifeng_signs_management_agreement_with_xian_qinba_xintong_medi/</loc>
		<lastmod>2018-07-04T15:45:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0549dlife_spine_launches_new_anterior_lumbar_fusion_s/</loc>
		<lastmod>2018-07-04T15:45:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/754a7alnylam_receives_20_million_milestone_payment_from_t/</loc>
		<lastmod>2018-07-04T15:45:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-signs-potential-1bn-deal-with-ionis-and-akcea-on-cardiovascular-treatments-090117-5711640/</loc>
		<lastmod>2018-07-04T15:45:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-humira-biosimilar-shows-positive-top-line-results-060117-5710721/</loc>
		<lastmod>2018-07-04T15:45:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114a9calando_pharmaceuticals_wins_new_us_p/</loc>
		<lastmod>2018-07-04T15:45:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d495nexeon_initiates_enrollment_in_feasibility_study_of_protex_stent_s/</loc>
		<lastmod>2018-07-04T15:45:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/274b2wafergen_signs_distribution_agreements_for_smartslide_microincubation_s/</loc>
		<lastmod>2018-07-04T15:45:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba492sqi_diagnostics_names_new_senior_vp_of_sales_and_mark/</loc>
		<lastmod>2018-07-04T15:45:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3149dxtl_biopharmaceuticals_completes_phase_iib_diabetic_neuropathic_pain_/</loc>
		<lastmod>2018-07-04T15:45:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f4a9ariad_pharmaceuticals_names_two_new_board_me/</loc>
		<lastmod>2018-07-04T15:45:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0649bpipex_wins_approval_to_initiate_phase_ii_fibromyalgia_/</loc>
		<lastmod>2018-07-04T15:45:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4b2vical_signs_loi_with_anges_for_pandemic_influenza_pr/</loc>
		<lastmod>2018-07-04T15:45:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/744a8peregrine_completes_enrollment_in_first_stage_of_phase_ii_cancer_/</loc>
		<lastmod>2018-07-04T15:45:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614afmyriad_genetics_licenses_drug_management_technology_from_saladax_biome/</loc>
		<lastmod>2018-07-04T15:45:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-starts-phase-1-trial-of-sgn-cd352a-for-patients-with-relapsed-or-refractory-mm-5710776/</loc>
		<lastmod>2018-07-04T15:45:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-pvp-biologics-partner-to-develop-novel-therapeutic-for-celiac-disease-060117-5710764/</loc>
		<lastmod>2018-07-04T15:45:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kalobios-secures-green-light-from-fda-to-proceed-with-chagas-disease-drug-060117-5710758/</loc>
		<lastmod>2018-07-04T15:45:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4adatherogenics_files_for_chapter_11_bankr/</loc>
		<lastmod>2018-07-04T15:45:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/464a8eden_spine_wins_ce_mark_for_wellex_interspinous_medical_d/</loc>
		<lastmod>2018-07-04T15:45:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d34aenewcardio_establishes_new_office_in_princeton_new_j/</loc>
		<lastmod>2018-07-04T15:45:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa499paragon_restructures_company_to_form_nexeon_medsy/</loc>
		<lastmod>2018-07-04T15:45:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2048fbiothera_completes_enrollment_of_first_arm_of_colorectal_cancer_/</loc>
		<lastmod>2018-07-04T15:45:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinical-stage-biopharmaceutical-firm-microbion-raises-25m-in-funding-060117-5710751/</loc>
		<lastmod>2018-07-04T15:45:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-janssen-enter-into-new-immunotherapy-clinical-research-collaboration-060117-5710566/</loc>
		<lastmod>2018-07-04T15:45:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/scientists-identify-how-cancer-cells-can-shrug-off-physical-constraints-on-growth-and-spread-100117-5713320/</loc>
		<lastmod>2018-07-04T15:45:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce48camo_wins_fda_approval_for_new_ophthalmic_viscosurgical_d/</loc>
		<lastmod>2018-07-04T15:45:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a24a1k2m_names_ne/</loc>
		<lastmod>2018-07-04T15:45:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/56480takeda_reports_encouraging_data_from_two_phase_iii_esophagitis_st/</loc>
		<lastmod>2018-07-04T15:45:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2d4a9cortexs_second_phase_iia_respiratory_depression_study_meets_end_/</loc>
		<lastmod>2018-07-04T15:45:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b8496volcano_relocates_corporate_headquarters_to_san_/</loc>
		<lastmod>2018-07-04T15:45:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-bayers-stivarga-marketing-application-for-liver-cancer-050117-5709870/</loc>
		<lastmod>2018-07-04T15:45:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apt-therapeutics-partners-with-astrazeneca-for-human-apyrase-therapy-050117-5709795/</loc>
		<lastmod>2018-07-04T15:45:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-ironwoods-nda-for-gout-drug-duzallo-050117-5709700/</loc>
		<lastmod>2018-07-04T15:45:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/324a7complete_genomics_and_isb_form_partne/</loc>
		<lastmod>2018-07-04T15:45:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b496concert_pharmaceuticals_names_new_senior_vice_president_an/</loc>
		<lastmod>2018-07-04T15:45:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24b5pharmengs_cfo_re/</loc>
		<lastmod>2018-07-04T15:45:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b495neri_names_new_vice_president_of_biome/</loc>
		<lastmod>2018-07-04T15:45:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/394bdtrinity_biotech_names_ne/</loc>
		<lastmod>2018-07-04T15:45:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ionis-type-2-diabetes-candidate-shows-positive-results-in-phase-2-study-050117-5709717/</loc>
		<lastmod>2018-07-04T15:45:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rana-therapeutics-acquires-mrt-platform-from-shire-050117-5709708/</loc>
		<lastmod>2018-07-04T15:45:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sun-pharmas-dry-eye-drug-seciera-demonstrates-positive-results-in-phase-3-trial-050117-5709615/</loc>
		<lastmod>2018-07-04T15:45:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/73489endocare_names_new_interim_president_an/</loc>
		<lastmod>2018-07-04T15:45:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/newvacs-ovarian-cancer-combination-meets-primary-endpoints-in-phase-ii-trial-040117-5709102/</loc>
		<lastmod>2018-07-04T15:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cannabics-pharmaceuticals-unveils-new-dosage-of-5mg-thc-cannabis-capsule-040117-5709080/</loc>
		<lastmod>2018-07-04T15:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/contracts/tracon-signs-spa-deal-with-fda-for-phase-3-trial-of-trc105-in-angiosarcoma-040117-5709065/</loc>
		<lastmod>2018-07-04T15:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc493isotechnika_announces_first_sale_of_voclos/</loc>
		<lastmod>2018-07-04T15:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd49fgene_express_licenses_biomarker_technology_to_abasta/</loc>
		<lastmod>2018-07-04T15:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/40491genaera_reports_positive_data_from_phase_i_study_of_diabetes_and_obesity/</loc>
		<lastmod>2018-07-04T15:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/12483caprion_wins_129_million_biomarker_research_contract_from_/</loc>
		<lastmod>2018-07-04T15:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ascletis-completes-100m-series-b-financing-5709058/</loc>
		<lastmod>2018-07-04T15:46:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9548cwelichem_biotechs_director_re/</loc>
		<lastmod>2018-07-04T15:46:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/924b2dendreon_reports_encouraging_interim_data_from_phase_iii_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:46:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/marinus-secures-orphan-drug-designation-for-fxs-candidate-ganaxolone-in-us-040117-5709028/</loc>
		<lastmod>2018-07-04T15:46:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zynerba-starts-phase-2-trial-of-zyn002-in-fragile-x-syndrome-040117-5708907/</loc>
		<lastmod>2018-07-04T15:46:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4a9healthsport_signs_reseller_agreement_with/</loc>
		<lastmod>2018-07-04T15:46:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a2oncalis_signs_licensing_agreement_with_ch/</loc>
		<lastmod>2018-07-04T15:46:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a8493unigene_initiates_phase_i_osteoporosis_/</loc>
		<lastmod>2018-07-04T15:46:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biondvax-secures-28m-investment-from-marius-nacht-fund-030117-5708438/</loc>
		<lastmod>2018-07-04T15:46:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/factor-one-source-pharmacy-to-buy-fast-access-specialty-therapeutics-030117-5708399/</loc>
		<lastmod>2018-07-04T15:46:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-boehringer-complete-swap-of-animal-consumer-health-assets-in-most-markets-030117-5708187/</loc>
		<lastmod>2018-07-04T15:46:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4acgenentech_and_biogen_idecs_phase_iii_leukemia_study_meets_end/</loc>
		<lastmod>2018-07-04T15:46:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f548dcombinatorxs_phase_iib_osteoarthritis_study_fails_end/</loc>
		<lastmod>2018-07-04T15:46:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a489pharmasset_names_new_vp_of_investor_relations_and_corporate_communica/</loc>
		<lastmod>2018-07-04T15:46:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e487medx_wins_fda_clearance_for_oralase_portable_/</loc>
		<lastmod>2018-07-04T15:46:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64aborexigen_presents_positive_results_from_phase_i_trials_of_weight_loss/</loc>
		<lastmod>2018-07-04T15:46:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bavarian-nordic-starts-trial-of-cv301-in-combination-with-nivolumab-for-lung-cancer-020117-5707868/</loc>
		<lastmod>2018-07-04T15:46:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tetralogic-completes-sale-of-smac-mimetic-hdac-inhibitor-assets-to-medivir-020117-5707861/</loc>
		<lastmod>2018-07-04T15:46:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innocolls-postsurgical-pain-drugdevice-fails-to-get-fda-review-020117-5707729/</loc>
		<lastmod>2018-07-04T15:46:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6494perrigo_acquires_laboratorios/</loc>
		<lastmod>2018-07-04T15:46:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f249fchina_medical_technologies_acquires_hpvdna_biosensor_chip_and_spr_s/</loc>
		<lastmod>2018-07-04T15:46:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d48bbavarian_nordic_reports_positive_results_for_phase_ii_cancer_vaccine_/</loc>
		<lastmod>2018-07-04T15:46:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774bcsalix_reports_encouraging_results_from_phase_iii_encephalopathy_/</loc>
		<lastmod>2018-07-04T15:46:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094a3ucb_reports_positive_results_from_phase_iiib_crohns_disease_/</loc>
		<lastmod>2018-07-04T15:46:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/incyte-treats-first-patient-in-clinical-trial-program-for-ruxolitinib-in-gvhd-020117-5707687/</loc>
		<lastmod>2018-07-04T15:46:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-concerta-tablets-in-us-to-treat-adhd-301216-5707418/</loc>
		<lastmod>2018-07-04T15:46:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81495cvrx_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:46:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a84b4given_imaging_introduces_new_rapid_5_access_sof/</loc>
		<lastmod>2018-07-04T15:46:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c487avexa_names_new_chairman_bolsters_board_of_dire/</loc>
		<lastmod>2018-07-04T15:46:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/96491ariad_announces_favorable_ruling_in_amgen_patent_litig/</loc>
		<lastmod>2018-07-04T15:46:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zydus-acquires-six-brands-from-msd-in-india-291216-5706924/</loc>
		<lastmod>2018-07-04T15:46:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/30486sirion_introduces_topical_ophthalmic_pain/</loc>
		<lastmod>2018-07-04T15:46:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3f49fovation_pharmaceuticalss_atryn_bla_accepted_for_review_b/</loc>
		<lastmod>2018-07-04T15:46:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c4b3biocept_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:46:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/49496chindex_international_to_open_guangzhou_united_family_health_c/</loc>
		<lastmod>2018-07-04T15:46:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6488genomequest_names_ne/</loc>
		<lastmod>2018-07-04T15:46:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df48fantisoma_announces_collaboration_with_the_institute_of_cancer_res/</loc>
		<lastmod>2018-07-04T15:46:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/servier-buys-development-and-commercialization-rights-of-oses-effi-7-281216-5706466/</loc>
		<lastmod>2018-07-04T15:46:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kubota-sbi-holdings-to-form-jv-for-ophthalmic-drugs-and-devices-development-271216-5705834/</loc>
		<lastmod>2018-07-04T15:46:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-divests-small-molecule-antibiotics-business-to-pfizer-261216-5705208/</loc>
		<lastmod>2018-07-04T15:46:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b4bcushifu_names_new_director_of_regulatory_affairs_of_focus_su/</loc>
		<lastmod>2018-07-04T15:46:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6485the_medicines_company_reports_positive_results_from_antihypertensive_drug_/</loc>
		<lastmod>2018-07-04T15:46:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexions-eculizumab-fails-to-meet-primary-endpoint-in-phase-23-trial-231216-5704535/</loc>
		<lastmod>2018-07-04T15:46:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f4acbioms_receives_positive_review_for_phase_iii_multiple_sclerosis_/</loc>
		<lastmod>2018-07-04T15:46:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454b0lilly_to_acquire_imclone_systems_for_65_bi/</loc>
		<lastmod>2018-07-04T15:46:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3548ecelgene_wins_marketing_approval_for_oral_myeloma_drug_in_c/</loc>
		<lastmod>2018-07-04T15:46:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ionis-gets-5m-from-jannsen-for-gi-related-program-231216-5704571/</loc>
		<lastmod>2018-07-04T15:46:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novelions-subsidiary-seeks-european-approval-for-metreleptin-231216-5704553/</loc>
		<lastmod>2018-07-04T15:46:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-emicizumab-haemophilia-drug-succeeds-in-phase-iii-trial-231216-5704508/</loc>
		<lastmod>2018-07-04T15:46:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genticel-and-genkyotex-sign-agreement-to-merge-5704434/</loc>
		<lastmod>2018-07-04T15:46:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovios-zika-vaccine-evokes-strong-response-in-first-human-trial-221216-5703624/</loc>
		<lastmod>2018-07-04T15:46:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dermavant-enters-into-licensing-agreement-with-portola-for-cerdulatinib-221216-5703679/</loc>
		<lastmod>2018-07-04T15:46:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/incyte-merus-to-collaborate-on-bispecific-antibodies-221216-5703664/</loc>
		<lastmod>2018-07-04T15:46:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e4acdecode_genetics_files_ind_application_for_cognition/</loc>
		<lastmod>2018-07-04T15:46:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe48alaborie_medical_technologies_signs_distribution_agreement_with_/</loc>
		<lastmod>2018-07-04T15:46:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/93494cell_therapeutics_names_new_president_of_european_opera/</loc>
		<lastmod>2018-07-04T15:46:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-agrees-to-acquire-encore-vision-221216-5703334/</loc>
		<lastmod>2018-07-04T15:46:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/77486sectra_signs_fiveyear_it_contract_with_region_/</loc>
		<lastmod>2018-07-04T15:46:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c482power3_medical_products_to_market_diagnostic_/</loc>
		<lastmod>2018-07-04T15:46:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/944a8natus_medical_acquires_neurocom_internat/</loc>
		<lastmod>2018-07-04T15:46:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4b8sound_surgical_names_new_cto_and_vp_o/</loc>
		<lastmod>2018-07-04T15:46:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c483lilly_signs_licensing_and_collaboration_agreement_with_deci/</loc>
		<lastmod>2018-07-04T15:46:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334b3physiocontrol_wins_fda_approval_for_lifepak_20e_defibrillatormo/</loc>
		<lastmod>2018-07-04T15:46:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4b1ablynx_wins_e18_million_grant_fro/</loc>
		<lastmod>2018-07-04T15:46:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merrimack-halts-breast-cancer-treatment-trial-221216-5703311/</loc>
		<lastmod>2018-07-04T15:46:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fluor-to-build-novo-nordisks-2bn-api-manufacturing-facility-in-north-carolina-211216-5702888/</loc>
		<lastmod>2018-07-04T15:46:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-starts-hiv-prevention-study-with-cabotegravir-211216-5702581/</loc>
		<lastmod>2018-07-04T15:46:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/x-chem-taiho-collaborate-on-multi-target-drug-discovery-technology-211216-5702666/</loc>
		<lastmod>2018-07-04T15:46:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-perrigos-generic-nicorette-white-ice-mint-gum-211216-5702634/</loc>
		<lastmod>2018-07-04T15:46:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-extends-bla-review-of-genentechs-ocrevus-211216-5702612/</loc>
		<lastmod>2018-07-04T15:46:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624afcovance_signs_drug_development_services_agreement_with_/</loc>
		<lastmod>2018-07-04T15:46:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f4bfaxcess_medical_imaging_names_ne/</loc>
		<lastmod>2018-07-04T15:46:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a648bcaridianbct_initiates_whole_blood_process_with_mirasol_prt_/</loc>
		<lastmod>2018-07-04T15:46:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a6496jubilant_organosys_and_lilly_to_establish_rd_joint_ve/</loc>
		<lastmod>2018-07-04T15:46:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4a5bharat_serums_and_vaccines_develops_new_formulation_of_cancer/</loc>
		<lastmod>2018-07-04T15:46:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-secures-rights-to-psioxus-armed-oncolytic-virus-211216-5702401/</loc>
		<lastmod>2018-07-04T15:46:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-commences-phase-iii-study-for-triple-combination-asthma-therapy-201216-5701328/</loc>
		<lastmod>2018-07-04T15:46:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/akcea-therapeutics-metabolic-disorder-drug-succeeds-in-phase-3-trial-201216-5701393/</loc>
		<lastmod>2018-07-04T15:46:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a4b6crucell_wins_niaidnih_contract_for_development_of_filovirus_va/</loc>
		<lastmod>2018-07-04T15:46:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44a1genentech_glycart_and_roche_sign_collaboration_agre/</loc>
		<lastmod>2018-07-04T15:46:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/40482spinesmith_signs_distribution_agreement_with_wave_manufact/</loc>
		<lastmod>2018-07-04T15:46:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094a1york_pharma_acquires_rights_to_two_skin_care_products_from_s/</loc>
		<lastmod>2018-07-04T15:46:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c495amgen_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:46:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo-nordisks-diabetes-drug-tresiba-gets-fda-approval-for-expanded-indication-201216-5701384/</loc>
		<lastmod>2018-07-04T15:46:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-gets-approval-for-expanded-indication-for-nimenrix-in-europe-201216-5701361/</loc>
		<lastmod>2018-07-04T15:46:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-partners-with-conatus-on-new-oral-treatments-for-chronic-liver-diseases-201216-5701193/</loc>
		<lastmod>2018-07-04T15:46:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db495micromet_raises_40_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:46:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544a6pangenetics_wins_approval_to_initiate_psoriatic_arthritis_/</loc>
		<lastmod>2018-07-04T15:46:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/024a1resmed_launches_sleep_apnea_study_in_heart_failure_pat/</loc>
		<lastmod>2018-07-04T15:46:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4b2bayer_reports_positive_results_from_phase_ii_hypertension_drug_/</loc>
		<lastmod>2018-07-04T15:46:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f4b4novartiss_phase_iii_asthma_study_in_children_meets_end/</loc>
		<lastmod>2018-07-04T15:46:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-and-celgene-to-collaborate-on-disease-modifying-therapeutics-191216-5700269/</loc>
		<lastmod>2018-07-04T15:46:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-drops-boxed-warning-on-pfizers-smoking-cessation-drug-191216-5700251/</loc>
		<lastmod>2018-07-04T15:46:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-to-acquire-ziarco-to-expand-dermatology-portfolio-191216-5700215/</loc>
		<lastmod>2018-07-04T15:46:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f24a4pfizer_and_boehringer_ingelheim_present_positive_results_of_copd_/</loc>
		<lastmod>2018-07-04T15:46:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/69494genentech_and_osis_phase_iii_lung_cancer_study_fails_end/</loc>
		<lastmod>2018-07-04T15:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec480galenea_and_otsuka_expand_research_partne/</loc>
		<lastmod>2018-07-04T15:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644b2biolex_therapeutics_secures_60_million_in_series_d_fina/</loc>
		<lastmod>2018-07-04T15:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4b5basilea_pharmaceutica_wins_german_approval_for_chronic_hand_eczema/</loc>
		<lastmod>2018-07-04T15:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-gets-ema-nod-for-first-line-use-in-certain-lung-cancer-191216-5700148/</loc>
		<lastmod>2018-07-04T15:47:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab485biolex_acquires_full_commercial_rights_to_hepatitis/</loc>
		<lastmod>2018-07-04T15:47:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b648bsynthemed_announces_key_management_ch/</loc>
		<lastmod>2018-07-04T15:47:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e2496stemcells_wins_nih_grant_to_develop_cellbased_therapeutic_for_hepa/</loc>
		<lastmod>2018-07-04T15:47:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actavis-uk-accused-of-breaking-competition-law-by-charging-unfair-prices-191216-5700152/</loc>
		<lastmod>2018-07-04T15:47:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-research-bicycle-partner-on-new-advanced-solid-tumour-therapy-161216-5699177/</loc>
		<lastmod>2018-07-04T15:47:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/554b2salvador_imaging_acquired_from_photon_dyn/</loc>
		<lastmod>2018-07-04T15:47:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4bcchina_biologic_to_acquire_90_controlling_interest_in_/</loc>
		<lastmod>2018-07-04T15:47:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d495methylgene_wins_canadian_approval_for_phase_i_fungal_d/</loc>
		<lastmod>2018-07-04T15:47:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a1498exelixis_files_ind_application_for_cancer/</loc>
		<lastmod>2018-07-04T15:47:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/204a8uroplasty_initiates_enrollment_for_overactive_bladder_/</loc>
		<lastmod>2018-07-04T15:47:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinigen-enters-into-supply-and-distribution-agreement-with-bioq-161216-5699162/</loc>
		<lastmod>2018-07-04T15:47:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter-to-acquire-indias-claris-injectables-for-625m-161216-5699086/</loc>
		<lastmod>2018-07-04T15:47:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vtv-therapeutics-ttp273-meets-primary-endpoint-in-phase-2-study-in-type-2-diabetes-161216-5699123/</loc>
		<lastmod>2018-07-04T15:47:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84a5interrad_wins_clearance_for_securacath_with_subcutaneous_securement_s/</loc>
		<lastmod>2018-07-04T15:47:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/024b4athera_signs_collaboration_agreement_with/</loc>
		<lastmod>2018-07-04T15:47:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d48dintradigm_raises_185_million_in_series_b_fina/</loc>
		<lastmod>2018-07-04T15:47:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f4beaeterna_enters_second_stage_of_patient_recruitment_for_phase_ii_cancer_/</loc>
		<lastmod>2018-07-04T15:47:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4b1merck_terminates_development_of_obesity_d/</loc>
		<lastmod>2018-07-04T15:47:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4b7lilly_reportedly_in_negotiations_to_buy_imclone_sy/</loc>
		<lastmod>2018-07-04T15:47:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734acorexigen_initiates_phase_iia_antipsychoticassociated_weight_gain_/</loc>
		<lastmod>2018-07-04T15:47:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-subsidiary-wins-25bn-patent-verdict-against-gilead-sciences-161216-5699104/</loc>
		<lastmod>2018-07-04T15:47:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza-agrees-to-acquire-capsugel-for-55bn-161216-5698847/</loc>
		<lastmod>2018-07-04T15:47:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vistagen-grants-exclusive-sublicense-to-bluerock-for-cardiac-stem-cell-technologies-151216-5697889/</loc>
		<lastmod>2018-07-04T15:47:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d491lilly_to_initiate_second_phase_iii_study_of_alzheimers/</loc>
		<lastmod>2018-07-04T15:47:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e6486chembio_and_oswaldo_cruz_foundation_sign_supply_and_licensing_agre/</loc>
		<lastmod>2018-07-04T15:47:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224b6cardinal_health_settles_controlled_substance_license_suspen/</loc>
		<lastmod>2018-07-04T15:47:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4b8hillrom_acquires/</loc>
		<lastmod>2018-07-04T15:47:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a482bayer_wins_marketing_approval_for_anticoagulant/</loc>
		<lastmod>2018-07-04T15:47:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/third-rock-launches-goldfinch-bio-for-kidney-disease-work-151216-5697863/</loc>
		<lastmod>2018-07-04T15:47:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intercepts-ocaliva-gets-ec-approval-for-treating-primary-biliary-cholangitis-151216-5697834/</loc>
		<lastmod>2018-07-04T15:47:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-and-astellas-xtandi-fails-to-meet-primary-endpoint-in-phase-4-trial-151216-5697791/</loc>
		<lastmod>2018-07-04T15:47:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1549daccess_pharmaceuticals_reports_encouraging_data_from_cancer_/</loc>
		<lastmod>2018-07-04T15:47:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/28490cayenne_medical_names_new_vice_president_of_/</loc>
		<lastmod>2018-07-04T15:47:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8349dspectrascience_wins_canadian_patent_for_optical_biopsy_s/</loc>
		<lastmod>2018-07-04T15:47:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/63484impedimed_and_metagenics_sign_distribution_agre/</loc>
		<lastmod>2018-07-04T15:47:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d4a1vwr_international_acquires_om/</loc>
		<lastmod>2018-07-04T15:47:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-reportedly-in-talks-to-buy-swiss-drug-maker-actelion-151216-5697654/</loc>
		<lastmod>2018-07-04T15:47:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/redhill-recommended-continuing-phase-3-study-of-crohns-disease-drug-141216-5696516/</loc>
		<lastmod>2018-07-04T15:47:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferrings-follitropin-delta-gets-eu-approval-141216-5696615/</loc>
		<lastmod>2018-07-04T15:47:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b8498celldex_receives_10_million_milestone_payment_from_affiliate_o/</loc>
		<lastmod>2018-07-04T15:47:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proton-partners-to-open-new-cancer-centre-in-reading-uk-141216-5696586/</loc>
		<lastmod>2018-07-04T15:47:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304b1roche_diagnostics_and_exiqon_amend_licensing_agre/</loc>
		<lastmod>2018-07-04T15:47:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584b2pharmaleads_wins_french_approval_for_phase_i_study_of_neuropathic_pain/</loc>
		<lastmod>2018-07-04T15:47:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4bctransave_secures_125_million_in_venture_fina/</loc>
		<lastmod>2018-07-04T15:47:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a9499anika_signs_distribution_agreement_with_canderm_p/</loc>
		<lastmod>2018-07-04T15:47:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-to-open-new-global-vaccines-rd-center-in-maryland-us-141216-5696565/</loc>
		<lastmod>2018-07-04T15:47:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sage-therapeutics-starts-phase-2-study-of-sage-217-in-movement-disorders-141216-5696399/</loc>
		<lastmod>2018-07-04T15:47:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe489bristolmyers_squibb_names_new_general_manager_of_devens_fac/</loc>
		<lastmod>2018-07-04T15:47:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/254b1cell_therapeutics_files_sbla_for_lymphoma/</loc>
		<lastmod>2018-07-04T15:47:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b493orthofix_international_wins_approval_for_firebird_lumbar_fixation_s/</loc>
		<lastmod>2018-07-04T15:47:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/744b7neurometrix_wins_fda_clearance_for_universal_elect/</loc>
		<lastmod>2018-07-04T15:47:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/grnenthal-to-buy-rights-to-pnp-drug-from-astellas-pharma-europe-131216-5695166/</loc>
		<lastmod>2018-07-04T15:47:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-synjardy-xr-tablets-for-adults-with-type-2-diabetes-131216-5695144/</loc>
		<lastmod>2018-07-04T15:47:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/874a0milestone_scientific_acquires_additional_patent_rights_to_painless_injec/</loc>
		<lastmod>2018-07-04T15:47:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-pharmaceuticals-names-david-brennan-as-interim-ceo-131216-5695127/</loc>
		<lastmod>2018-07-04T15:47:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/14491circassia_initiates_further_phase_ii_cat_allergy_/</loc>
		<lastmod>2018-07-04T15:47:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/70480sadra_medical_initiates_enrollment_in_european_study_of_lotus_valve_s/</loc>
		<lastmod>2018-07-04T15:47:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-versant-ventures-invest-225m-in-new-stem-cell-therapy-company-131216-5695083/</loc>
		<lastmod>2018-07-04T15:47:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza-confirms-interest-in-acquiring-capsugel-131216-5695020/</loc>
		<lastmod>2018-07-04T15:47:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2d4b5dara_biosciences_completes_toxicology_studies_of_insulin/</loc>
		<lastmod>2018-07-04T15:47:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104bdoptumhealth_and_state_of_ohio_renew_health_con/</loc>
		<lastmod>2018-07-04T15:47:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d4a1onepoint_patient_care_shifts_oklahoma_fac/</loc>
		<lastmod>2018-07-04T15:47:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-ribociclib-shows-significant-benefit-in-advanced-breast-cancer-121216-5693787/</loc>
		<lastmod>2018-07-04T15:47:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a748aopko_health_acquires_ophthalmic_rights_to_tevas_respiratory/</loc>
		<lastmod>2018-07-04T15:47:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/04493brainlab_to_obtain_438_million_lawsuit_costs_from_medt/</loc>
		<lastmod>2018-07-04T15:47:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4b0repros_therapeutics_secures_155_million_in_fina/</loc>
		<lastmod>2018-07-04T15:47:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b4bbadvanced_life_sciences_and_wyeth_sign_commercialization_agre/</loc>
		<lastmod>2018-07-04T15:47:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d4b3bioniche_pharma_wins_fda_approval_for_generic_ketala/</loc>
		<lastmod>2018-07-04T15:47:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valneva-gets-approvals-to-start-clinical-testing-of-lyme-disease-vaccine-candidate-121216-5693957/</loc>
		<lastmod>2018-07-04T15:47:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forge-therapeutics-evotec-establish-superbug-alliance-121216-5693935/</loc>
		<lastmod>2018-07-04T15:47:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/synergy-pharmaceuticals-bowel-drug-succeeds-in-phase-3-trial-121216-5693919/</loc>
		<lastmod>2018-07-04T15:47:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/19490surmodics_acquires_codelink_activated_slide_business_from_ge_healt/</loc>
		<lastmod>2018-07-04T15:47:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4b2pharmaxis_files_new_marketing_application_for_bronchiectasis_drug_in_aust/</loc>
		<lastmod>2018-07-04T15:47:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e4abbiochemics_signs_collaboration_agreement_with_cyn/</loc>
		<lastmod>2018-07-04T15:47:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e24a1bristolmyers_squibbs_hiv_combination_therapy_wins_fda_app/</loc>
		<lastmod>2018-07-04T15:47:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a49fambrilia_biopharma_reports_positive_results_from_phase_iii_acromegaly_/</loc>
		<lastmod>2018-07-04T15:47:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-eli-lilly-partner-for-another-alzheimers-drug-121216-5693737/</loc>
		<lastmod>2018-07-04T15:47:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biohavens-orphan-drug-designation-request-for-bhv-0223-granted-by-fda-091216-5692820/</loc>
		<lastmod>2018-07-04T15:47:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-files-seeks-nda-approval-for-sofosbuvir-velpatasvir-and-voxilaprevir-in-us-091216-5692782/</loc>
		<lastmod>2018-07-04T15:47:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiome-pharma-launches-xydalba-dalbavancin-in-uk-091216-5692755/</loc>
		<lastmod>2018-07-04T15:47:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/endo-returns-rights-for-belbuca-to-biodelivery-sciences-international-091216-5692732/</loc>
		<lastmod>2018-07-04T15:47:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perrigo-plans-to-restructure-branded-consumer-healthcares-belgium-business-091216-5692545/</loc>
		<lastmod>2018-07-04T15:47:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c149cdna_direct_to_introduce_new_colorectal_cancer_screening/</loc>
		<lastmod>2018-07-04T15:47:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/054a9inotek_pharmaceuticals_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:47:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizon-pharma-stops-development-of-actimmune-for-friedreichs-ataxia-091216-5692520/</loc>
		<lastmod>2018-07-04T15:47:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/researchers-stumble-on-visual-stimulation-technique-for-treating-alzheimers-081216-5691371/</loc>
		<lastmod>2018-07-04T15:47:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/aclaris-starts-phase-1-trial-for-ati-50001-to-treat-alopecia-totalis-and-alopecia-universalis-081216-5691511/</loc>
		<lastmod>2018-07-04T15:47:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a3489vgx_pharmaceuticals_wins_235_million_nih_con/</loc>
		<lastmod>2018-07-04T15:47:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2949bcrucell_reports_positive_results_from_phase_ii_rabies_/</loc>
		<lastmod>2018-07-04T15:47:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/94493regenerx_seeks_partner_for_cystic_fibrosis_drug_develo/</loc>
		<lastmod>2018-07-04T15:47:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sermonix-signs-licensing-deal-to-further-explore-lasofoxifene-for-breast-cancer-treatment-081216-5691502/</loc>
		<lastmod>2018-07-04T15:47:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cascadian-therapeutics-begins-phase-2-trial-of-tucatinib-081216-5691402/</loc>
		<lastmod>2018-07-04T15:47:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european-commission-approves-new-indication-for-novartis-lucentis-eye-drug-081216-5691019/</loc>
		<lastmod>2018-07-04T15:47:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/754beexiqon_licenses_diagnostic_technology_to_roche_diagnost/</loc>
		<lastmod>2018-07-04T15:47:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f84acironwood_pharmaceuticals_secures_50_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:47:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce497ppd_acquires_inno/</loc>
		<lastmod>2018-07-04T15:47:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4a7immunogen_names_ne/</loc>
		<lastmod>2018-07-04T15:47:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/delta_lloyd_acquires_5_4perc_of_galapagos/</loc>
		<lastmod>2018-07-04T15:47:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-zykadia-beats-chemotherapy-in-late-stage-lung-cancer-study-071216-5690171/</loc>
		<lastmod>2018-07-04T15:47:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-gets-fda-approval-for-bevacizumab-071216-5690062/</loc>
		<lastmod>2018-07-04T15:47:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/theravances-velusetrag-td-5108-fast-tracked-by-fda-071216-5690042/</loc>
		<lastmod>2018-07-04T15:47:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd4adpharmathene_and_panacea_biotec_form_strategic_all/</loc>
		<lastmod>2018-07-04T15:47:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5548aevalve_completes_enrollment_for_mitral_regurgitation_/</loc>
		<lastmod>2018-07-04T15:47:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15488qmed_terminates_collaboration_agreement_with_med/</loc>
		<lastmod>2018-07-04T15:47:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e494cellumen_signs_partnership_agreement_with/</loc>
		<lastmod>2018-07-04T15:47:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384aeadvinus_and_orthomcneiljanssen_form_drug_discovery_collabor/</loc>
		<lastmod>2018-07-04T15:47:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-and-flynn-fined-90m-for-overpricing-anti-epilepsy-drug-in-uk-071216-5690006/</loc>
		<lastmod>2018-07-04T15:47:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-tagrisso-reduces-lung-cancer-progression-by-70-in-phase-iii-study-071216-5689789/</loc>
		<lastmod>2018-07-04T15:47:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/purdue-pharma-anabios-partner-to-advance-research-for-non-opioid-non-nsaid-compounds-061216-5688799/</loc>
		<lastmod>2018-07-04T15:47:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4b4cempra_signs_research_agreement_with_bio/</loc>
		<lastmod>2018-07-04T15:47:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4b5ge_healthcare_acquires_agility_healthcare_solu/</loc>
		<lastmod>2018-07-04T15:47:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d3496seattle_genetics_names_new_executive_me/</loc>
		<lastmod>2018-07-04T15:47:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/in-phase-1-study-of-orally-administered-aminoglycoside-antibiotic-mat2501-5688779/</loc>
		<lastmod>2018-07-04T15:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aegerion-pharmaceuticals-signs-licensing-deal-with-amryt-pharma-for-lojuxta-061216-5688764/</loc>
		<lastmod>2018-07-04T15:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo-nordisk-seeks-fda-and-ema-approvals-for-semaglutide-061216-5688662/</loc>
		<lastmod>2018-07-04T15:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8849evaxinnates_second_flu_vaccine_canditate_enters_clinical_develo/</loc>
		<lastmod>2018-07-04T15:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f849fimclone_commences_enrollment_for_phase_ii_ovarian_cancer_/</loc>
		<lastmod>2018-07-04T15:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-bosulif-found-superior-to-gleevec-in-late-stage-study-in-type-of-leukemia-061216-5688482/</loc>
		<lastmod>2018-07-04T15:48:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-and-allergan-submit-bevacizumab-biosimilar-application-to-ema-051216-5687391/</loc>
		<lastmod>2018-07-04T15:48:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b9490enzon_granted_orphan_drug_status_for_new_cancer_drug_/</loc>
		<lastmod>2018-07-04T15:48:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a849alink_medicine_raises_40_million_in_series_c_fina/</loc>
		<lastmod>2018-07-04T15:48:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc48dforest_and_gedeon_report_positive_reults_from_phase_ii_bipolar_i_disorder_/</loc>
		<lastmod>2018-07-04T15:48:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shires-vonvendi-meets-primary-endpoint-in-phase-3-trial-051216-5687370/</loc>
		<lastmod>2018-07-04T15:48:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/204b3plethora_completes_european_phase_iii_premature_ejaculation_/</loc>
		<lastmod>2018-07-04T15:48:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a485ge_healthcare_acquires_mic/</loc>
		<lastmod>2018-07-04T15:48:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-glasdegib-meets-primary-end-point-in-phase-2-trial-051216-5687349/</loc>
		<lastmod>2018-07-04T15:48:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-and-innoviva-seek-eu-approval-for-copd-therapy-candidate-051216-5687325/</loc>
		<lastmod>2018-07-04T15:48:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-cardiovascular-indication-for-jardiance-051616-5687245/</loc>
		<lastmod>2018-07-04T15:48:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d048caeolus_initiates_phase_i_amyotrophic_lateral_sclerosis_/</loc>
		<lastmod>2018-07-04T15:48:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6548bindevus_initiates_phase_iii_acromegaly_/</loc>
		<lastmod>2018-07-04T15:48:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c49bhelix_biopharma_announces_114_million_private_plac/</loc>
		<lastmod>2018-07-04T15:48:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6048avanguard_pharmaceutical_names_new_pres/</loc>
		<lastmod>2018-07-04T15:48:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/agilis-gene-therapy-candidate-gets-orphan-designation-approval-in-europe-021216-5686257/</loc>
		<lastmod>2018-07-04T15:48:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acadia-begins-phase-2-trial-of-depression-treating-drug-candidate-021216-5686215/</loc>
		<lastmod>2018-07-04T15:48:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyos-breast-cancer-drug-candidate-gets-fast-tracked-by-fda-021216-5686175/</loc>
		<lastmod>2018-07-04T15:48:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94beapt_pharmaceuticals_raises_32_million_in_series_b_fina/</loc>
		<lastmod>2018-07-04T15:48:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/12489takeda_files_nda_for_actos_od_tablets_in_japan/</loc>
		<lastmod>2018-07-04T15:48:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a648ftakeda_submits_nda_for_diabetes_drug_in_/</loc>
		<lastmod>2018-07-04T15:48:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bicycle-astrazeneca-enter-into-potential-1bn-multitarget-collaboration-021216-5686064/</loc>
		<lastmod>2018-07-04T15:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-ibm-partner-to-advance-immuno-oncology-research-021216-5686026/</loc>
		<lastmod>2018-07-04T15:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heptares-to-acquire-g7-therapeutics-to-expand-gpcr-capabilities-011216-5684849/</loc>
		<lastmod>2018-07-04T15:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b48ebsv_signs_licensing_and_supply_agreement_with_ac/</loc>
		<lastmod>2018-07-04T15:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b749csiemens_wins_government_contract_to_develop_ultrasound_hemorrhage_d/</loc>
		<lastmod>2018-07-04T15:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144a8bioimaging_names_new_president_of_phoenix_data_systems_div/</loc>
		<lastmod>2018-07-04T15:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644abvertellus_specialties_to_expand_vitamin_b3_production_capacity_in_/</loc>
		<lastmod>2018-07-04T15:48:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a492covalon_names_ne/</loc>
		<lastmod>2018-07-04T15:48:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3849btekmira_names_two_new_executive_me/</loc>
		<lastmod>2018-07-04T15:48:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34abpotentia_pharmaceuticals_reports_positive_results_of_phase_i_amd_/</loc>
		<lastmod>2018-07-04T15:48:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e14b6stratatechs_stratagraft_skin_substitute_trial_meets_end_/</loc>
		<lastmod>2018-07-04T15:48:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/natrix-partners-with-merck-sanofi-on-protein-a-platform-5684883/</loc>
		<lastmod>2018-07-04T15:48:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-risankizumab-secures-fda-orphan-drug-status-for-paediatric-crohns-011216-5684870/</loc>
		<lastmod>2018-07-04T15:48:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c495response_genetics_partners_with_neogenomics_to_offer_cancer_/</loc>
		<lastmod>2018-07-04T15:48:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4649dantigenics_granted_permission_for_export_of_cancer_vaccine_to_r/</loc>
		<lastmod>2018-07-04T15:48:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e04a7synvista_granted_approval_to_initiate_phase_ii_psoriasis_/</loc>
		<lastmod>2018-07-04T15:48:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-merck-sign-deals-to-partner-on-target-discovery-technologies-011216-5684856/</loc>
		<lastmod>2018-07-04T15:48:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc48bibex_technologies_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:48:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e8486cepheid_wins_fda_clearance_to_market_molecular_diagnostic/</loc>
		<lastmod>2018-07-04T15:48:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c48etelormedix_raises_19_million_in_series_a_fina/</loc>
		<lastmod>2018-07-04T15:48:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74bflimerick_neurosciences_changes_name_to_limerick_biop/</loc>
		<lastmod>2018-07-04T15:48:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474bfcardinal_health_to_spin_off_clinical_and_medical_products_busin/</loc>
		<lastmod>2018-07-04T15:48:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/73486micronics_granted_two_new_patents_on_microfluidic_technol/</loc>
		<lastmod>2018-07-04T15:48:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d484ambrilia_biopharma_prioritizes_its_divestment_strategy_implements_costcu/</loc>
		<lastmod>2018-07-04T15:48:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-herceptin-biosimilar-succeeds-in-breast-cancer-study-011216-5684500/</loc>
		<lastmod>2018-07-04T15:48:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-to-establish-dengue-vaccine-manufacturing-plant-in-germany-301116-5683612/</loc>
		<lastmod>2018-07-04T15:48:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/west-pharmaceutical-services-expands-contract-manufacturing-capabilities-in-ireland-301116-5683589/</loc>
		<lastmod>2018-07-04T15:48:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/254b3medimmune_licenses_reverse_genetics_technology_to_/</loc>
		<lastmod>2018-07-04T15:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4a7antisoma_initiates_phase_ii_breast_cancer_/</loc>
		<lastmod>2018-07-04T15:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e495vgx_initiates_followon_phase_i_study_for_antiinflammatory/</loc>
		<lastmod>2018-07-04T15:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxthera-raises-eur32m-to-complete-oxabact-development-to-treat-primary-hyperoxaluria-301116-5683554/</loc>
		<lastmod>2018-07-04T15:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ergomed-buys-european-pharmacovigilance-and-regulatory-services-business-pharminvent-5683522/</loc>
		<lastmod>2018-07-04T15:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxford-biomedica-partners-with-orchard-therapeutics-5683513/</loc>
		<lastmod>2018-07-04T15:48:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48482transmolecular_initiates_dosing_in_phase_iii_malignant_glioma_/</loc>
		<lastmod>2018-07-04T15:48:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de497elite_announces_fda_acceptance_of_synthetic_narcotic_analgesic_drug/</loc>
		<lastmod>2018-07-04T15:48:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-priority-review-to-emd-seronos-bla-for-avelumab-for-merkel-cell-carcinoma-301116-5683357/</loc>
		<lastmod>2018-07-04T15:48:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a48crepros_therapeutics_to_secure_156_million_in_fina/</loc>
		<lastmod>2018-07-04T15:48:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c0488avant_immunotherapeutics_to_change_name_to_celldex_therape/</loc>
		<lastmod>2018-07-04T15:48:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/catalent-to-acquire-softgel-maker-accucaps-291116-5682347/</loc>
		<lastmod>2018-07-04T15:48:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/patheon-agrees-to-buy-roches-api-manufacturing-plant-in-south-carolina-291116-5682321/</loc>
		<lastmod>2018-07-04T15:48:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1348elifeline_biotechnologies_names_new_president_of_first_warning_sy/</loc>
		<lastmod>2018-07-04T15:48:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/03490axiomed_spine_initiates_pivotal_study_of_spinal_d/</loc>
		<lastmod>2018-07-04T15:48:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2848fkendle_names_new_director_of_investor_rela/</loc>
		<lastmod>2018-07-04T15:48:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a496fei_installs_cryoelectron_microscopy_solution_at_sun_p/</loc>
		<lastmod>2018-07-04T15:48:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/814a6lilly_wins_fda_approval_for_lung_cancer/</loc>
		<lastmod>2018-07-04T15:48:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154b4aethlon_medical_begins_first_clinical_study_of_hemopurifier_for_hiv_trea/</loc>
		<lastmod>2018-07-04T15:48:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e488bayer_and_national_university_of_singapore_partner_in_cancer_res/</loc>
		<lastmod>2018-07-04T15:48:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a3490daiichi_sankyos_subsidiary_to_close_osaka_/</loc>
		<lastmod>2018-07-04T15:48:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-signs-deal-with-medicines-patent-pool-to-expand-access-to-hepatitis-c-medicines-in-developing-countries-291116-5682303/</loc>
		<lastmod>2018-07-04T15:48:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recro-pharma-reph-announces-iv-meloxicam-phase-3-met-primary-endpoint-5682291/</loc>
		<lastmod>2018-07-04T15:48:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/744b2oni_biopharma_licenses_gene_targets_for_colorectal_c/</loc>
		<lastmod>2018-07-04T15:48:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54afcubist_pharmaceuticals_establishes_new_research_facility_in_lexi/</loc>
		<lastmod>2018-07-04T15:48:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-mercks-sbla-for-keytruda-for-msi-h-cancer-291116-5682197/</loc>
		<lastmod>2018-07-04T15:48:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8448fnoven_names_new_vice_president_of_quality_assurance__quality_co/</loc>
		<lastmod>2018-07-04T15:48:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/24496dynavax_wins_17_million_contract_fro/</loc>
		<lastmod>2018-07-04T15:48:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f64b9proteinexpert_changes_name_to_pxtherape/</loc>
		<lastmod>2018-07-04T15:48:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/92482mindray_names_new_board_me/</loc>
		<lastmod>2018-07-04T15:48:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covidien_to_implement_corporate_restructuring/</loc>
		<lastmod>2018-07-04T15:48:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/16480biologics_provides_prescriptions_for_new_oral_lung_cancer/</loc>
		<lastmod>2018-07-04T15:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94b3clinical_data_raises_25_million_in_fina/</loc>
		<lastmod>2018-07-04T15:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/93485tyrx_introduces_aigisrx_antibacterial_env/</loc>
		<lastmod>2018-07-04T15:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9349fenteromedics_reports_encouraging_data_from_obesity_/</loc>
		<lastmod>2018-07-04T15:49:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4a9biotronik_wins_ce_mark_for_new_biotronik_home_monitoring_s/</loc>
		<lastmod>2018-07-04T15:49:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c049dnomad_bioscience_signs_licensing_agreement_with_bayer_and_icon_gen/</loc>
		<lastmod>2018-07-04T15:49:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5483scolrs_anda_for_cdtbased_pseudoephedrine_accepted_for_review_b/</loc>
		<lastmod>2018-07-04T15:49:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/204b3columbia_laboratories_presents_findings_from_phase_ii_dysmenorrhea_/</loc>
		<lastmod>2018-07-04T15:49:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/604afgetting_ready_and_winston_laboratories_complete_merger_agre/</loc>
		<lastmod>2018-07-04T15:49:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d34aememory_pharmaceuticals_completes_phase_i_alzheimers_/</loc>
		<lastmod>2018-07-04T15:49:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e49b4antibody_names_new_/</loc>
		<lastmod>2018-07-04T15:49:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51493holliseden_reports_additional_findings_from_phase_iii_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:49:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48493cigna_names_new_dir/</loc>
		<lastmod>2018-07-04T15:49:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f3498basi_names_new_vice_president_of_sales_and_mark/</loc>
		<lastmod>2018-07-04T15:49:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e49epharmathene_wins_multiyear_contract_from_/</loc>
		<lastmod>2018-07-04T15:49:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd4a0thrombogenics_reports_positive_results_from_phase_ii_stroke_/</loc>
		<lastmod>2018-07-04T15:49:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6480regeneron_reports_encouraging_results_from_phase_ii_amd_/</loc>
		<lastmod>2018-07-04T15:49:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d48femergent_biosolutions_signs_297_million_contract_with_barda/</loc>
		<lastmod>2018-07-04T15:49:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e4b1fda_continues_to_review_daiichi_sankyo_and_lillys_prasugre/</loc>
		<lastmod>2018-07-04T15:49:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd48bverax_biomedical_granted_ce_mark_for_platelet_pgd/</loc>
		<lastmod>2018-07-04T15:49:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4a8tryton_medical_introduces_side_branch_stent_system_in_e/</loc>
		<lastmod>2018-07-04T15:49:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c496indevus_signs_licensing_and_development_agreement_with/</loc>
		<lastmod>2018-07-04T15:49:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/75492breckenridge_signs_loi_wit/</loc>
		<lastmod>2018-07-04T15:49:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f4486gi_dynamics_reports_encouraging_results_of_endobarrier_gastrointestinal_/</loc>
		<lastmod>2018-07-04T15:49:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884bedr_reddys_wins_fda_approval_for_arthritis_pain/</loc>
		<lastmod>2018-07-04T15:49:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/22496morphosys_and_shionogi_extend_research_partne/</loc>
		<lastmod>2018-07-04T15:49:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/79490clarient_signs_training_and_consulting_agreement_with_flow_cytometr/</loc>
		<lastmod>2018-07-04T15:49:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/95497safc_pharma_commissions_new_hpapi_facility_at_st_/</loc>
		<lastmod>2018-07-04T15:49:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc498wuxi_pharmatech_opts_out_of_joint_venture_with_covance_in_/</loc>
		<lastmod>2018-07-04T15:49:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64a0takeda_withdraws_marketing_application_for_insomnia_drug_in_e/</loc>
		<lastmod>2018-07-04T15:49:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af499png_gerolymatos_introduces_saline_nasal_spray_/</loc>
		<lastmod>2018-07-04T15:49:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f4aemedicult_to_acquire_midatlantic_diagno/</loc>
		<lastmod>2018-07-04T15:49:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f04b7safc_pharma_expands_api_manufacturing_facility_in_ir/</loc>
		<lastmod>2018-07-04T15:49:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/24491eli_lillys_schizophrenia_drug_wins_eu_positive_op/</loc>
		<lastmod>2018-07-04T15:49:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a9481holliseden_reports_positive_interim_data_from_phase_iii_diabetes_tr/</loc>
		<lastmod>2018-07-04T15:49:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/434aaivax_diagnostics_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:49:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c497ipsen_announces_filing_of_sixmonth_formulation_of_prostate_cancer/</loc>
		<lastmod>2018-07-04T15:49:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/86492molecular_insight_pharmaceuticals_names_new_interi/</loc>
		<lastmod>2018-07-04T15:49:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154aeclarient_and_definiens_form_partners/</loc>
		<lastmod>2018-07-04T15:49:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c14b9map_pharmaceuticals_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:49:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/754a6morphotek_and_pivotal_biosciences_sign_development_agre/</loc>
		<lastmod>2018-07-04T15:49:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614b2monosol_rx_raises_20_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:49:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4a6cryocath_settles_patent_suits_with_cryocor_and_ams_res/</loc>
		<lastmod>2018-07-04T15:49:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/364b9osteotech_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:49:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd48bmedtronic_to_acquire_cryocath_technol/</loc>
		<lastmod>2018-07-04T15:49:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774aaarray_biopharmas_diabetes_drug_found_to_be_effective_in_preclinical_st/</loc>
		<lastmod>2018-07-04T15:49:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a481nuvelo_and_arca_biopharma_sign_merger_agreem/</loc>
		<lastmod>2018-07-04T15:49:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db481amerisourcebergen_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:49:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1949cteva_and_kowa_form_partners/</loc>
		<lastmod>2018-07-04T15:49:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774aaboston_scientific_wins_approval_for_taxus_express2_atom_stent_s/</loc>
		<lastmod>2018-07-04T15:49:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f04b1thallion_initiates_enrollment_for_phase_ii_brain_cancer_/</loc>
		<lastmod>2018-07-04T15:49:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f495merck_signs_licensing_agreement_with_japan_to/</loc>
		<lastmod>2018-07-04T15:49:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014b3ucb_withdraws_eu_marketing_application_for_diabetic_pain/</loc>
		<lastmod>2018-07-04T15:49:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584acalphatec_wins_fda_approval_for_cervical_im/</loc>
		<lastmod>2018-07-04T15:49:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af4a0imclone_systems_initiates_enrollment_for_phase_ii_breast_cancer_/</loc>
		<lastmod>2018-07-04T15:49:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b491concert_pharmaceuticals_initiates_phase_i_hot_flashes_/</loc>
		<lastmod>2018-07-04T15:49:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e648amacrogenics_secures_25_million_in_fina/</loc>
		<lastmod>2018-07-04T15:49:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4a5pdl_biopharma_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:49:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b24b23sbio_files_for_chinese_approval_of_anemia/</loc>
		<lastmod>2018-07-04T15:49:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4b4oxygen_biotherapeutics_names_ne/</loc>
		<lastmod>2018-07-04T15:49:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/714a6biomerieux_to_develop_new_prostate_cancer_diagnostic/</loc>
		<lastmod>2018-07-04T15:49:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144a7sanofi_pasteur_acquires_acambis_for_gbp285_mi/</loc>
		<lastmod>2018-07-04T15:49:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/954b4pharming_group_nominates_ne/</loc>
		<lastmod>2018-07-04T15:49:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/menarini-silicons-deparray-aids-researchers-in-lung-cancer-study-281116-5681069/</loc>
		<lastmod>2018-07-04T15:49:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intellipharmaceutics-seeks-fda-approval-for-rexista-281116-5681035/</loc>
		<lastmod>2018-07-04T15:49:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-seeks-eu-approval-for-shingles-vaccine-281116-5681004/</loc>
		<lastmod>2018-07-04T15:49:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664b3novagali_pharma_raises_e15_million_in_fina/</loc>
		<lastmod>2018-07-04T15:49:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/09497sanofiaventis_launches_dscreen_conso/</loc>
		<lastmod>2018-07-04T15:49:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/94481medco_health_solutions_announces_senior_management_ch/</loc>
		<lastmod>2018-07-04T15:49:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d149dcorgenix_medical_wins_third_us_patent_for_atherox_techn/</loc>
		<lastmod>2018-07-04T15:49:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774aequark_pharmaceuticals_announces_first_sirna_drug_cand/</loc>
		<lastmod>2018-07-04T15:49:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/nice-approves-leukaemia-drug-for-routine-treatment-option-281116-5680793/</loc>
		<lastmod>2018-07-04T15:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c482guided_therapeutics_completes_subject_enrollment_in_cancer_device_/</loc>
		<lastmod>2018-07-04T15:50:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b485sagent_acquires_rights_to_infusive_technologiess_syringe_techn/</loc>
		<lastmod>2018-07-04T15:50:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1048aalbumax_wins_medicaid_approval_in_california_and_pennsyl/</loc>
		<lastmod>2018-07-04T15:50:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d495water_street_healthcare_completes_agreement_with_gentiva_health_ser/</loc>
		<lastmod>2018-07-04T15:50:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson-johnson-in-talks-to-buy-swiss-drug-maker-actelion-281116-5680910/</loc>
		<lastmod>2018-07-04T15:50:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-begins-phase-iii-study-of-daprodustat-in-ckd-patients-with-anaemia-251116-5679861/</loc>
		<lastmod>2018-07-04T15:50:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf4bdbiomarins_partner_merck_wins_eu_positive_opinion_for_phenylketonuria/</loc>
		<lastmod>2018-07-04T15:50:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4a7delcath_adds_providence_cancer_center_to_phase_iii_melanoma_/</loc>
		<lastmod>2018-07-04T15:50:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b6493bioview_reports_encouraging_interim_results_of_lung_cancer_diagnostic/</loc>
		<lastmod>2018-07-04T15:50:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bavarian-completes-enrollment-of-phase-3-non-inferiority-study-of-imvamune-smallpox-vaccine-251116-5679833/</loc>
		<lastmod>2018-07-04T15:50:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orchard-therapeutics-and-ucla-secure-20m-funding-from-californias-stem-cell-agency-251116-5679810/</loc>
		<lastmod>2018-07-04T15:50:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b481morphosys_exercises_option_to_participate_in_novartis_antibody_pr/</loc>
		<lastmod>2018-07-04T15:50:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/71485advanced_cancer_therapeutics_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:50:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e0487dyax_completes_bla_for_hereditary_angioedema/</loc>
		<lastmod>2018-07-04T15:50:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/green-cross-gets-complete-response-letter-from-fda-for-ivig-sn-251116-5679759/</loc>
		<lastmod>2018-07-04T15:50:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk-biopharmaceutical-firm-kymab-secures-100m-of-funding-251116-5679484/</loc>
		<lastmod>2018-07-04T15:50:29+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->